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FUNCTIONAL CHARACTERIZATION OF THE ARGININE TRANSAMINASE 
PATHWAY IN PSEUDOMONAS AERUGINOSA PAO1 
by 
ZHE YANG 
Under the Direction of Chung-Dar Lu 
 
ABSTRACT 
Arginine utilization in Pseudomonas aeruginosa with multiple catabolic pathways 
represents one of the best examples of metabolic versatility of this organism. To identify 
genes of this complex arginine network, we employed DNA microarray to analyze the 
transcriptional profiles of this organism in response to L-arginine. While most genes in 
arginine uptake, regulation and metabolism have been identified as members of the ArgR 
regulon in our previous study, eighteen putative transcriptional units of 38 genes 
including the two known genes of the arginine dehydrogenase (ADH) pathway, kauB and 
gbuA, were found inducible by exogenous L-arginine but independent of ArgR.  
The potential physiological functions of those candidate genes in L-arginine 
utilization were studied by growth phenotype analysis in knockout mutants. The insertion 
mutation of aruH encoding an L-arginine:pyruvate transaminase abolished the capability 
to grow on L-arginine of an aruF mutant devoid of a functional arginine 
succinyltransferase (AST) pathway, the major route of arginine utilization. The aruH 
gene was cloned and over-expressed in E. coli. Taking L-arginine and pyruvate as the 
substrates, the reaction products of recombinant enzyme were identified by MS and 
 HPLC as 2-ketoarginine and L-alanine. Lineweaver-Burk plots of the data revealed a 
series of parallel lines characteristic of ping-pong kinetics mechanism, and the apparent 
Km and catalytic efficiency (Kcat/Km) were 1.6 ± 0.1 mM and 24.1 mM-1 s-1 for pyruvate 
and 13.9 ± 0.8 mM and 2.8 mM-1 s-1 for L-arginine. Recombinant AruH showed an 
optimal pH at 9.0 and substrate specificity with an order of preference being Arg > Lys > 
Met > Leu > Orn > Gln. These data led us to propose the arginine transaminase (ATA) 
pathway that removes the α-amino group of L-arginine via transamination instead of 
oxidative deamination by dehydrogenase or oxidase as originally proposed. In the same 
genetic locus, we also identified a two-component system, AruRS, for the regulation of 
arginine-responsive induction of the ATA pathway.  
Our latest DNA microarray experiments under D-arginine conditions also revealed 
PA3863 as the candidate gene encoding D-arginine dehydrogenase which might lead to 
the recognition of a wider network of arginine metabolism than we previously 
recognized. 
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General Introduction 
Biosynthesis and metabolism of arginine in microorganisms have been carefully 
reviewed in many aspects (Abdelal, 1979; Cunin et al., 1986; Haas, 1990; Itoh, 2004; Lu, 
2006). In this introduction, only the information related to this dissertation is briefly 
summarized and discussed. 
 
0.1 ARGININE CATABOLISM BY MICROORGANISMS. 
Arginine can serve a broad range of microorganisms as a growth substrate, a building 
block of proteins and a precursor of polyamine synthesis. All the major arginine catabolic 
pathways are initiated by one of the following five chemical reactions (Fig. 0.1): 1) the 
hydrolytic cleavage of arginine by arginase forms ornithine and urea; 2) arginine 
deamination produces citrulline and ammonia; 3) the decarboxylation of arginine 
generates agmatine, which is then converted into putrescine; 4) the transamination or 
oxidation of the α-nitrogen atom of arginine results in the generation of 2-ketoarginine; 
and 5) the succinyl-coenzyme A dependent succinylation of arginine initiates the 
conversion of arginine to glutamate and succinate (Cunin et al., 1986). Remarkably, 
multiple arginine catabolic pathways were frequently found in the same organism, 
especially among the members of pseudomonas species (Cunin et al., 1986; Haas, 1990; 
Itoh, 2004). The possession of different arginine catabolic pathways in these bacteria may 
have particular survival significance to them in fluctuating environments. Therefore, the 
study of arginine catabolism by microorganism will provide exciting findings in the fields 
of enzymology, genetic regulation mechanisms and metabolic physiology.  
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0.2 P. AERUGINOSA IS A GOOD MODEL MICROORGANISM TO STUDY 
ARGININE CATABOLISM.  
P. aeruginosa is a Gram-negative bacterium that causes life-threatening infections in 
immunocompromised persons and chronic infections in cystic fibrosis patients (Rahme et 
al., 1995). The potential pathogenicity of this opportunistic human pathogen is greatly 
enhanced by its extraordinary nutritional versatility, which gives it an exceptional ability 
to colonize ecological niches where nutrients are limited (Stover et al., 2000).  
Arginine catabolism is of particular significance in P. aeruginosa, which can utilize 
arginine efficiently as the sole source of carbon, nitrogen and energy through four 
different pathways: the arginine deiminase (ADI) pathway, the arginine 
succinyltransferase (AST) pathway, the arginine decarboxylase (ADC) pathway and the 
arginine dehydrogenase (ADH, also called arginine oxidase) pathway (Haas, 1990; Itoh, 
2004; Lu, 2006). The decarboxylation of arginine generates agmatine, which can be 
further converted into putrescine and spermidine. The presence of multiple arginine 
catabolic pathways and the link of arginine to polyamine biosynthesis constitute a 
complicated metabolic network of arginine and polyamines in this organism (Haas, 1990; 
Itoh, 2004; Lu, 2006). Therefore, P. aeruginosa serves as an excellent model organism 
for studying arginine catabolism.  
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0.3 ARGR AND ARGININE CATABOLISM IN P. AERUGINOSA  
There are four pathways for L-arginine catabolism in P. aeruginosa. Under anaerobic 
conditions, L-arginine can be used by P. aeruginosa mainly through the ADI pathway to 
provide ATP to support its motility and slow growth (Vander Wauven et al., 1984). Anr, 
the anaerobic regulatory protein (Gamper et al., 1991), is essential for the induction of the 
arcDABC operon, which encodes an arginine: ornithine antiporter and the enzymes of the 
ADI pathway. Exogenous L-arginine can further induce the expression of this operon 
through the interaction of Anr with the arginine-responsive regulatory protein, ArgR 
(Park et al., 1997a; Park et al., 1997b). On the other hand, under aerobic conditions, L-
arginine can be used by P. aeruginosa through the AST, ADC and ADH pathways. The 
AST pathway is the major route of L-arginine utilization by P. aeruginosa (Itoh, 1997). 
An aru-null mutation almost abolishes the L-arginine utilization by this strain (Itoh, 
2004). The AST pathway converts L-arginine to glutamate and succinate by five 
enzymatic steps (Fig. 1.1). Both the aru operon encoding the enzymes of the AST 
pathway and the gdhB gene encoding a catabolic glutamate dehydrogenase are induced 
by ArgR in the presence of exogenous L-arginine (Lu and Abdelal, 1999; Lu and 
Abdelal, 2001; Park et al., 1997a). The ADC pathway converts L-arginine into putrescine 
via agmatine and N-carbamoyl putrescine and it is assumed that this pathway supplies 
polyamines when arginine is abundant (Haas, 1990; Mercenier et al., 1980). The speA 
and adcA genes of the ADC pathways are again regulated by ArgR. In P. aeruginosa, 
ArgR is autoinduced by exogenous L-arginine from aotjQMOP-argR operon and its 
DNA-binding activity appears to be independent of L-arginine (Nishijyo et al., 1998; 
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Park et al., 1997a; Park et al., 1997b). Thus for all the above three pathways (the ADI, 
AST and ADC pathways) of L-arginine catabolism, ArgR is the positive regulator. 
 
0.4 PROPOSAL OF THE ADH PATHWAY. 
The above mentioned three pathways are well characterized in P. aeruginosa. 
However, very little is known about the fourth L-arginine catabolic pathway, the ADH 
pathway. The ADH pathway was first discovered in Streptomyces griseus (Cunin et al., 
1986), then in P. putida (Vanderbilt et al., 1975) and P. aeruginosa (Voellym and 
Leisinger, 1976). Using the ADH pathway, S. griseus degrades L-arginine via 4-
guanidinobutyramide, 4-guanidinobutyrate (4-GB), 4-aminobutyrate and succinate 
semialdehyde. The ADH pathway in P. aeruginosa (Haas, 1990) and P. putida are 
similar but not identical to that in S. griseus. As shown in figure 1.1, L-arginine is first 
oxidized into 2-ketoarginine by L-arginine oxidase. Then 2-ketoarginine is converted to 
4-guanidinobutyraldehyde (GUBAL) by 2-ketoarginine decarboxylase. 4-
guanidinobutyraldehyde dehydrogenase successively catalyzes the formation of 4-GB. 
Subsequent intermediates are 4-aminobutyrate and succinate semialdehyde which is 
finally channeled into the tricarboxylic acid (TCA) cycle. The ADH pathway in P. putida 
was proposed based on detection of the intermediates of L-arginine catabolism and 
further demonstration of the predicted enzymes involved in those steps. To detect those 
intermediates of the ADH pathway, L-[U-
14
C] arginine were incubated with intact cells 
and with cell extracts. The reaction mixtures were then fractionated by paper 
chromatography and high voltage electrophoresis (Miller, 1972; Vanderbilt et al., 1975). 
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The enzymes of the ADH pathway were demonstrated by enzyme assays from cell crude 
extract (Chou and Rodwell, 1972; Jann et al., 1988; Miller, 1972; Vanderbilt et al., 1975). 
P. aeruginosa can utilize all the compounds below 2-ketoarginine as good carbon and 
nitrogen sources (Stalon and Mercenier, 1984). By analogy, it was expected that the same 
pathway existed in P. aeruginosa (Haas, 1990).  
Though P. aeruginosa possesses the same set of the enzymes downstream of 2-
ketoarginine decarboxylase as P. putida (Fig. 1.1), all the attempts to demonstrate the 
presence of L-arginine oxidase in P. aeruginosa were unsuccessful (Jann et al., 1988). 
The activity of L-arginine: 2-oxoglutatate transaminase, another enzyme catalyzing the 
conversion of L-arginine to 2-ketoarginine, could not be detected in this microorganism 
either. The discovery of a D-arginine inducible D-arginine dehydrogenase (Jann et al., 
1988) provided the possible route for D-arginine utilization in P. aeruginosa eventually.  
Since current research regarding the ADH pathway mainly focuses on the nature of 
the enzymatic steps involved, little is known about the genes encoding the enzymes of the 
ADH pathway. Only gbuA gene encoding guanidinobutyrase of the ADH pathway has 
been characterized (Nakada and Itoh, 2002). kauB gene encoding 4-
guanidinobutyraldehyde dehydrogenase (Jann et al., 1988), gabD gene encoding 
succinate-semialdehyde dehydrogenase and gabT gene encoding 4-
aminobutyrateaminotransferase have just been mapped in P. aeruginosa but not yet 
cloned. The genes, which encode arginine oxidase/dehydrogenase/transaminase and 2-
ketoarginine decarboxylase for the first two steps of the ADH pathway, are still 
unknown. In order to fully understand the regulatory mechanism of arginine network in 
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P. aeruginosa, it is crucial to identify and characterize the unknown genes of the ADH 
pathway.  
 
0.5 DNA MICROARRAY AND CELL METABOLISM.  
Identification of genes responsible for certain catabolic pathway usually includes the 
following steps: 1) demonstration of proposed enzymatic activity; 2) purification of the 
protein responsible for this enzymatic activity; 3) determination of peptide sequence for 
this protein; 4) conversion of protein sequence into DNA sequence; and 5) gene cloning 
and over-expression. Or, genome-wide transposon mutagenesis may also be a choice 
when combined with the screening of phenotypic mutants. Those traditional approaches 
are time-consuming, and sometimes may not be feasible. 
Recent technological advances have made it possible to study global gene expression 
in both prokaryotic and eukaryotic organisms by using high density oligonucleotide 
microarray. The complete sequence of the genome of P. aeruginosa strain PAO1 has 
been published in 2000 (Stover et al., 2000), and the extraordinary nutritional versatility 
of this organism is reflected by its relatively large genome (6.3Mbp) and genetic 
complexity (5,570 open reading frames). Not surprisingly, the genome of P. aeruginosa 
possesses more than 9% of the assigned open reading frames which are classified as 
transcriptional regulators and two-component systems, reflecting the capability of the 
organism to adapt to changing environmental conditions (Stover et al., 2000). 
Considering little known genetic information of the ADH pathway and the relatively 
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large size of the P. aeruginosa genome, we chose the DNA microarray technology to 
identify the unknown genes of the ADH pathway in an efficient and systematic way.  
The P. aeruginosa Genome Array was developed by Affymetrix and the Cystic 
Fibrosis Foundation. The array represents the annotated genome of P. aeruginosa strain 
PA01 and includes 5,549 protein-coding sequences, 18 tRNA genes, a representative of 
the ribosomal RNA cluster and 117 genes present in strains other than PAO1. In addition, 
199 probe sets corresponding to all intergenic regions exceeding 600 base pairs have 
been included. The selected probes have been screened against sequence homologies in 
the existing database of human genes. This GeneChip probe array is a powerful tool for 
monitoring transcriptional regulation and antimicrobial agent response of P. aeruginosa.  
In our DNA microarray experiments, the total RNA samples were prepared from P. 
aeruginosa wild type strain PAO1 and its argR mutant strain PAO501 grown in 
glutamate minimal medium P (MMP) in the presence and absence of L-arginine under 
aerobic conditions. Since the ArgR protein has proven to be an important regulator for 
arginine utilization in P. aeruginosa, we made the hypothesis for the expression patterns 
for those arginine metabolic genes (Fig. 0.2). For those arginine biosynthetic genes, they 
may show basal levels of expression in the wild type strain PAO1 and its argR mutant 
strain PAO501 grown in the absence of L-arginine. When the bacteria cells are grown in 
the presence of L-arginine, those arginine biosynthetic genes may be repressed and this 
arginine repression effect may be abolished when the regulatory protein, ArgR, is 
inactivated. Similarly, those arginine catabolic genes may show basal levels of expression 
in the wild type strain PAO1 and its argR mutant strain PAO501 grown in the absence of 
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L-arginine. However, those arginine catabolic genes may be induced when the bacteria 
cells are grown in the presence of L-arginine and this arginine induction effect may be 
abolished when the regulatory protein, ArgR, is inactivated as shown in Fig 0.2. 
This dissertation analyzed the transcriptional profiles of P. aeruginosa in response to 
L-arginine and D-arginine. The AruH and AruI were identified as an L-arginine: pyruvate 
transaminase and a 2-ketoarginine decarboxylase, respectively. To our knowledge, this is 
the first report of an arginine transaminase being characterized at the molecular level. 
Based on these results, we proposed the arginine transaminase (ATA) pathway that 
removes the α-amino group of L-arginine via transamination to replace the ADH 
pathway as originally proposed. We also demonstrated the roles of the AruR and AruS 
proteins in the regulation of the ATA pathway. Last, it is noteworthy that our recent DNA 
microarray data strongly suggested that the PA3863 gene may encode a D-arginine 
dehydrogenase.  
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FIG. 0.1. Diagram of arginine structure and known catabolic reactions. 
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FIG. 0.2. Predicted gene expression patterns of the arginine metabolic genes identified by 
DNA microarray. WT, P. aeruginosa wild type strain PAO1; argR, P. aeruginosa argR 
mutant strain PAO501; G, glutamate minimal medium P (MMP); G+A, glutamate MMP 
with L-arginine. Illustrated are the arginine catabolic genes (square), the arginine 
biosynthetic genes (circle) and the third type of genes (triangle). 
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Chapter One 
Functional Genomics Approach Enables the Identification of Genes of the Arginine 
Transaminase Pathway in Pseudomonas aeruginosa  
 
1.1 INTRODUCTION 
Arginine utilization in pseudomonads can be mediated by multiple catabolic 
pathways (Fig. 1.1). The arginine deiminase (ADI) pathway encoded by the arc operon 
(Gamper et al., 1991; Haas, 1990; Vander Wauven et al., 1984) provides ATP to support 
slow growth under anaerobic conditions. The arginine succinyltransferase (AST) pathway 
encoded by the aru operon (Itoh, 1997) and the gdhB gene (Lu and Abdelal, 2001) is the 
major route of arginine utilization as the carbon and nitrogen source under aerobic 
conditions. The arginine decarboxylase (ADC) pathway may not contribute to arginine 
utilization due to the lack of an arginine-inducible ADC activity, but rather serve to 
supply putrescine when arginine is abundant (Itoh, 2004; Mercenier et al., 1980; Nakada 
and Itoh, 2003). Nevertheless, exogenous agmatine or putrescine indeed can induce all 
the enzymes following its entry point of the ADC pathway, and thus be utilized as the 
sole source of carbon and nitrogen through this pathway (Haas et al., 1984; Lu et al., 
2002; Nakada et al., 2001).  
The arginine dehydrogenase (ADH) pathway was considered as the second pathway 
for arginine utilization in P. aeruginosa under aerobic conditions. This is supported by 
the observation that while an aruF mutant without a functional AST pathway grew 
poorly on arginine as the sole source of carbon and nitrogen, an aruF gbuA double 
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mutant blocking both the AST and ADH pathways showed no growth on this amino acid 
(Itoh, 2004). Although the kauB and gbuA genes encoding 4-guanidinobutyraldehyde 
dehydrogenase and 4-guanidinobutyrase of the ADH pathway (Fig. 1.1) have been 
identified or characterized (Holloway et al., 1994; Jann et al., 1988; Nakada and Itoh, 
2002), genetic information for the initial steps of this pathway was completely 
unavailable. While the presence of an L-arginine oxidase activity has been reported in P. 
putida (Chou and Rodwell, 1972; Vanderbilt et al., 1975), this enzymatic activity has 
never been demonstrated in P. aeruginosa. Instead, the presence of a D-arginine 
inducible D-arginine dehydrogenase activity suggested an alternative route through this 
enzyme and an arginine racemase in P. aeruginosa (Jann et al., 1988). Although the 
removal of the α-amino group from L-arginine could be through either oxidative 
deamination or transamination, the results of previous studies did not favor 
transamination (Jann et al., 1988). 
The ArgR protein, a transcriptional regulator of the AraC/XylS family (Gallegos et 
al., 1997), controls arginine-dependent induction of the arc and aru operons and the gdhB 
gene in P. aeruginosa (Lu and Abdelal, 2001; Lu et al., 1999; Park et al., 1997b). ArgR is 
auto-induced by exogenous arginine from the aotJQMOP-argR operon for arginine and 
ornithine uptake and regulation (Nishijyo et al., 1998). The ArgR protein also serves as 
the repressor of the argF, argG, and carAB genes in arginine biosynthesis and the gdhA 
and gltBD genes in glutamate biosynthesis (Hashim et al., 2004; Lu et al., 2004; Park et 
al., 1997a; Park et al., 1997b). Over thirty genes of the ArgR regulon in P. aeruginosa 
have been identified by transcriptome analyses (Lu et al., 2004). The kauB and gbuA 
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genes of the ADH pathway were not identified as members of the ArgR regulon. In this 
report, we conducted further transcriptome analyses to identify genes including kauB and 
gbuA that are induced by exogenous L-arginine in the absence of ArgR. Identification of 
genes encoding an arginine:pyruvate transaminase and a putative 2-ketoarginine 
decarboxylase led us to propose that the α-amino group of L-arginine is removed via 
transamination instead of oxidative deamination by dehydrogenase or oxidase as 
originally proposed in the ADH pathway, and thus we proposed here to call this 
reformulated route the arginine transaminase (ATA) pathway. In the same genetic locus, 
we also identified a two-component system for the regulation of arginine-responsive 
induction of the ATA pathway. 
 
1.2 MATERIALS AND METHODS 
1.2.1 Strains, plasmids, and growth conditions.  
Major strains and plasmids used in this study are listed in Table 1.1. Luria-Bertani 
(LB) enriched medium (Schweizer, 1991) was used for strain construction with the 
following supplements as required: ampicillin, 50 µg/ml (for E. coli); carbenicillin, 100 
µg/ml (for P. aeruginosa); gentamicin, 100 µg/ml; streptomycin, 500 µg/ml; and 
tetracycline, 50 µg/ml. Minimal medium P (MMP) (Haas et al., 1977) was used for the 
growth of P. aeruginosa PAO strains with supplements of specific carbon and nitrogen 
sources at 20 mM as indicated. 
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1.2.2 RNA isolation, generation of cDNA probes, and data analysis.  
Total RNA was isolated using Qiagen RNeasy Kit, followed by DNase I treatment 
and column RNA purification (Qiagen). Labeled cDNA probes were prepared in 
accordance with the protocol provided by the manufacturer (Affymetrix). cDNA was 
synthesized by annealing random primers (Invitrogen) to purified total RNA and 
subsequent extension with reverse transcriptase (SuperScript II; Invitrogen). Spike RNAs 
corresponding to B. subtilis genes dap, thr, phe, lys, and trp were included in the cDNA 
synthesis reaction mixtures as an internal control to monitor the processes of labeling, 
hybridization, and scanning efficiency. 
The results of two independent experiments were merged for each of the following 
three growth conditions: wild-type strain PAO1 in glutamate MMP (1E), wild-type strain 
PAO1 in glutamate MMP plus L-arginine (1ER), and argR mutant strain PAO501 in 
glutamate MMP plus L-arginine (5ER). The merged data were used for subsequent 
comparisons and assessed with Microarray Suite 5.0 software (Affymetrix). Absolute 
expression signal values were normalized for each chip by globally scaling to a target 
intensity of 500. These data were imported into GeneSpring 6.1 software (Silicon 
Genetics) for further analysis based on distinct expression patterns in these three 
conditions. Transcripts with the absence call (P > 0.04) or with a signal level (5ER) 
below 400 were eliminated. 
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1.2.3 Construction of lacZ fusions.  
Plasmid pQF52 (Park et al., 1997a), a broad-host-range lacZ translational fusion 
vector, was used in the construction of promoter fusions of PA1421 (gbuA), PA2862 
(lipA), PA3865, PA4980 and PA5304 (dadA). DNA fragments containing the regulatory 
regions of interest were amplified by PCR from the genomic DNA of PAO1 with the 
following synthetic oligonucleotides designed to generate HindIII restriction sites on the 
forward primers: for PA1421 (gbuA), 5’-TTTAAGCTTCCAGTTCGCCGAGGATGCA 
GCAG-3’ and 5’-CTGGTGGAGATTCTTGTCCACGGGGTGGCC-3’; for PA2862 
(lipA), 5’-CCTAAGCTTCGCCCTGCCCTGCCCACCTCC-3’ and 5’-CTTCTTCATGT 
TGTTCTCATCTCAGGTTGA-3’; for PA3865, 5’-AGCAAGCTTCCCCCATTACAGA 
CGCGCCTC-3’ and 5’-GGTGTTCAGCGACTTGATCATGGACGACTC-3’; for 
PA4980, 5’-CCAAGCTTGGGCGACCCCGCCCTGGGACG-3’ and 5’-GGGGGAAAG 
GTCAGTCATGCGGCC-3’; for PA5304 (dadA), 5’-AGAAAGCTTGCCGGGCAGTAC 
GTCCAGGTC-3’ and 5’-CAGAACTCGCATTGTCGCCTCCCACGTCGC-3’. The 
PCR products were purified from a 1% (wt/vol) agarose gel, digested by restriction 
endonuclease HindIII, and ligated to the HindIII and SmaI sites of the translational fusion 
vector pQF52. The resulting plasmids contain the entire upstream intergenic sequences of 
the corresponding genes and the 5' ends of their coding sequences fused in-frame to the 
eighth codon of the lacZ gene in the vector.  
Another broad-host-range lacZ vector pQF50 (Farinha and Kropinski, 1990) was used 
to produce the transcriptional fusion constructs of kauB and PA5313. Two different DNA 
fragments were generated by PCR employing two oligonucleotide primers designed to 
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generate HindIII restriction sites at both 5’ and 3’ ends of the PA5312 (kauB)-PA5313 
intergenic region, 5’-CCGAAGCTTGAACTGGCGGTTGGCGGTGAA-3’ and 5’-
CACAAGCTTCGCCCTGCCCTGCCCACCTCC-3’. The PCR products were purified 
from a 1% (wt/vol) agarose gel, digested by restriction endonuclease HindIII, and ligated 
to the same site of the transcriptional fusion vector pQF50. Following the cloning strategy 
described above, the resulting two fusion plasmids were designated pZY7 and pZY8, 
respectively, which represent either PA5312 (kauB)::lacZ fusion or PA5313::lacZ fusion. 
The nucleotide sequences of the resulting constructs were verified by nucleotide sequence 
determination.  
 
1.2.4 Construction of mutant strains.  
The EZ::Tn5TM <TET-1> insertion system (Epicentre) was used for generation of 
knockout mutations. The 11-kb HindIII fragment covering the aruRS-aruI cluster was 
purified from cosmid pMO012227 (Pseudomonas Genetic Stock Center, PGSC) and 
subcloned into the same site of the conjugation vector pRTP1 (Stibitz et al., 1986). The 
resulting plasmid DNA was incubated with the transposase and the transposon with a 
tetracycline resistance marker, and the in vitro transposon insertion reaction was carried 
out under the conditions recommended by the manufacturer. After the reaction, the 
mixture was used to transform E. coli DH5α, and transformants were selected on LB 
plates with tetracycline. The insertion sites of mutant clones were mapped by HindIII 
restriction endonuclease digestion and subsequently by nucleotide sequencing with a 
transposon-specific flanking primer. For gene replacement, the resulting transposon 
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insertion plasmids were first introduced into E. coli SM10 and then mobilized into the 
spontaneous streptomycin-resistant P. aeruginosa strain PAO1-Sm and PAO4558-Sm by 
biparental plate mating (Gamper et al., 1991). After incubation at 37°C overnight, 
transconjugants were selected on LB plates supplemented with tetracycline and 
streptomycin.  
Knockout mutants of PA4975, PA4976 (aruH), and PA5304 (dadA) were also 
constructed by using the similar strategy as described above. DNA fragments covering 
those genes were generated by PCR from the genomic DNA of PAO1 with the following 
synthetic oligonucleotides designed to generate HindIII restriction sites at both 5’ and 3’ 
ends of the PCR products: for PA4975 and PA4976 (aruH), 5’-
GTCTAAGCTTGACTGGCCTGGCGCGCGTCG-3’ and 5’-CGCAAGCTTCGGGCAG 
TCCGGCGTGACCCT-3’; for PA5304 (dadA), 5’-ACGGAAGCTTGGGCCGCCAGCA 
TTTTTTA-3’ and 5’-ACCGAAGCTTTGGATATTTC CCGCTACAGC-3’. Genotypes 
of all these constructed mutants were verified by Southern blot.
 
1.2.5 Complementation of aruH and aruI mutants.  
The DNA fragment covering the PA4975 and aruH genes as described above was 
cloned into the HindIII site of pUCP18. Expression of these two genes in the resulting 
plasmid, pZY9, was under the control of the lac promoter. Competent cells of aruH and 
aruI mutants of P. aeruginosa were prepared for transformation by pZY9 following the 
standard protocols. 
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1.2.6 Enzyme assays.  
For the measurements of enzyme activities, cell cultures in the logarithmic phase were 
collected by centrifugation, and the cell pellets were washed twice using 50 mM 
potassium phosphate buffer, pH 7.0, and resuspended in the same buffer. Cells were 
broken with a French pressure cell at 8,000 lb/in2, and soluble cell extracts were prepared 
after centrifugation at 25,000 x g for 20 min. Protein concentration was determined by the 
method of Bradford with bovine serum albumin as the standard (Bradford, 1976). 
For the measurement of arginine:pyruvate transaminase activities, a two-step coupled 
reaction was used as described in Chapter Two (Yang and Lu, 2007a). Briefly, the 
reaction of arginine:pyruvate transamination generates 2-ketoarginine and alanine, and 
the concentration of alanine was determined by monitoring the formation of NADH from 
NAD+ in a coupled reaction with L-alanine dehydrogenase. In these reactions, anhydrous 
hydrazine was used to trap the remaining substrate pyruvate as well as the reaction 
product 2-ketoarginine as the hydrazones. Blanks did not contain L-arginine, pyruvate or 
cell extract. One unit of enzyme activity is defined as the amount of the enzyme that 
yielded 1 nmol of L-alanine per min under the standard assay conditions. The arginine 
transaminase activity was linear for up to 15 minutes with less than 100 units of enzymes 
in the first reaction. 
Arginine oxidase was assayed by measuring the release of ammonia from L-arginine 
in a coupled reaction with L-glutamate dehydrogenase under the conditions given by 
Miller and Rodwell (Reitz and Rodwell, 1970). For the measurements of β-galactosidase 
activity, o-nitrophenyl-β-D-galactopyranoside (ONPG) was used as the substrate (Miller, 
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1972). Blanks did not contain crude extract. The molar extinction coefficient (4860 M-
1cm-1) of ONPG at 420 nm was used for the calculation.  
 
1.2.7 Detection of enzymatic products of AruI by HPLC.  
An assay for 2-ketoarginine decarboxylase was reported previously (Miller and 
Rodwell, 1971) by measuring the liberated 14CO2. Here we used HPLC to analyze this 
enzymatic reaction. The reaction mixture contained, in a final volume of 0.3 ml: 100 mM 
potassium phosphate (pH 7.5), 0.5 mM thiamine pyrophosphate (TPP), 1 mM MgSO4, 1 
mM 2-ketoarginine, and crude extract (250 µg protein). The reaction was started by the 
addition of crude extracts, and incubated at 37 °C for 1 h. In the negative control 
experiments, heat-denatured crude extracts were used to prepare the reaction mixtures. 
After incubation, the samples were boiled for 10 min and then filtered using an Ultrafree-
0.5 PBCC centrifugal filter unit (molecular mass cut-off 5 kDa; Millipore). After 10-fold 
dilution (vol/vol) with deionized water, 30 µl of reaction samples were separated on a 
Breeze HPLC system (Waters) equipped with a Develosil RP-Aqueous C30 column (4.6 × 
250 mm; Phenomenex) at a flow rate of 1 ml/min. The mobile phase was 0.1 M 
potassium phosphate (pH 2.0), and elution was monitored by UV detection at 205 nm. 
Authentic 2-ketoarginine, 4-guanidinobutyraldehyde (GUBAL) and TPP (Sigma) were 
used as standards.  
GUBAL was prepared as described by Tanaka et al (Tanaka et al., 2001). Briefly, L-
Arginine hydrochloride monohydrate (100 mM) was exposed to a gentle flow of N2 for 5 
min. An equimolar amount of chloramine T (Sigma) was added to the above L-arginine 
 
 
 20
solution and incubated at 30°C for 1 h. The reaction byproduct, p-toluenesulfamide, and 
the non-utilized chloramine T were crystallized by placing the reaction mixture in an ice 
bath and then removed by filtration. The column (2.5×40 cm) of Dowex 50 (Bio-Rad 
Laboratories) was washed and equilibrated with 1000 ml deionized water and the crude 
preparation of 4-guanidinobutyraldehyde (80 ml) was then charged to the column. The 
column was then washed with 500 ml of ion exchange water. L-Arginine was eluted with 
2400 ml of 0.6 N HCl and then 4-guanidinobutyraldehyde with 2000 ml of 1.0 N HCl. 4-
Guanidinobutyraldehyde (800 ml) was neutralized with 3 N NaOH. 
A protocol described by Jann et al was followed to prepare 2-ketoarginine (2-KA) 
(Jann et al., 1988). L-Arginine hydrochloride monohydrate (9 mM) and n-octanol 
(antifoam, 0.5 ml) were added to 45 ml 10 mM potassium phosphate buffer (pH 7.1) 
containing 15 units of oxidase from Crotalus adamanteus (Sigma) and 60,000 units of 
catalases (Sigma). The reaction mixture was exposed to a gentle flow of O2 and incubated 
at 37 °C for 50 h or until the complete consumption of L-arginine. Using an Ultrafree-0.5 
PBCC centrifugal filter unit (molecular mass cut-off 5 kDa; Millipore), the oxidase was 
separated from the reaction mixture, and could be used two more times for 2-KA 
synthesis. The reaction products were separated by column chromatography using Dowex 
50-X8, H+ form (1.5×15 cm). Water, 0.1 M HCl and 1M HCl were used for elution. 2-
KA was obtained in 0.1 M HCl eluted fraction, and crystallized at 4 °C overnight. 
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1.3 RESULTS 
1.3.1 Identification of genes induced by L-arginine in the absence of ArgR.  
To better understand arginine metabolism in P. aeruginosa, we have employed DNA 
microarray to analyze the transcriptional profiles of this organism in response to L-
arginine. In the previous report (Lu et al., 2004), over thirty genes have been identified as 
members of the ArgR regulon, in which gene expression is either repressed or activated 
by exogenous L-arginine in the presence of a functional ArgR. These two groups of 
genes exhibited distinct expression profiles, as represented by argF for the repression 
group and aruF for the activation group (last two lanes; Table 1.2). In addition, ArgR 
binding sites have been demonstrated in these genes. To our surprise, genes of the 
proposed ADC and ADH pathways were not identified in the ArgR regulon. In this 
report, we described a third type of expression profile in which genes were highly 
induced by L-arginine in the argR mutant strain PAO501 but to a lesser extent in the wild 
type strain PAO1 (Fig. 0.2). 
Table 1.2 summarizes 38 genes in 18 putative transcriptional units falling into this 
group. While many of these genes have not been characterized, it was interesting to note 
the following three observations. Firstly, lipAH and PA4978-4980 genes are related to 
lipid or fatty acid metabolism. Secondly, gabDT and spuIABC genes have been reported 
inducible by agmatine or putrescine, and enzymes encoded by gabDT and spuC are part 
of the ADC pathway. These genes as well as dadX-PA5303-dadA, PA5309, and kauB-
PA5313-PA5314 genes were indeed induced to a high level by agmatine or putrescine in 
the wild type strain PAO1 from DNA microarray analysis. The kauB gene encodes a 
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bifunctional dehydrogenase for 4-aminobutyraldehyde of the ADC pathway and 4-
guanidinobutyraldehyde (GUBAL) of the ADH pathway. Thirdly, the gbuA gene 
encoding 4-guanidinobutyrase of the ADH pathway was also identified in this list. These 
results suggested that genes of the convergent ADC and ADH pathways (Fig. 1.1) might 
be cross-regulated, and that the genes for the first two steps of the ADH pathway yet to 
be identified might also be in the same gene list. 
 
1.3.2 Validation of microarray data by promoter::lacZ fusions.  
Genes in Table 1.2 (also Fig. 1.4) could be categorized into 18 putative transcriptional 
clusters. Promoters from seven of these clusters were selected for further analysis by lacZ 
fusions: gbuA, lipA, PA3865, PA4980, dadA, kauB and PA5313. These promoter::lacZ 
fusions were constructed as described in Materials and Methods, and the effect of ArgR 
and exogenous L-arginine on expression of these promoters was analyzed by 
measurements of β-galactosidase activities in PAO1 or the argR mutant harboring the 
recombinant plasmids. As shown in Table 1.3, all these fusions exhibited 2 to 15 fold 
higher L-arginine inducible promoter activities in the argR mutant than in the wild type 
PAO1. Overall, these results correlated well with microarray data in the induction 
pattern, and supported the presence of an additional arginine-responsive regulatory 
mechanism besides that controlled by ArgR. 
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1.3.3 The gbuA locus.  
The gbuA gene (PA1421) encodes a guanidinobutyrase (Nakada and Itoh, 2002) for 
the conversion of 4-guanidinobutyrate to 4-aminobutyrate in the proposed ADH pathway 
(Fig. 1.1). It is the first gene of a putative 7-gene operon (PA1421-PA1415) as suggested 
by the correlated expression profiles of these genes from microarray data (Table 1.2). 
Among these genes, PA1416 and PA1417 were annotated to encode a FAD-linked 
oxidase and a decarboxylase, respectively, which might catalyze the first two reactions of 
the ADH pathway. Although our enzyme assay results for L-arginine oxidase did not 
support the presence of L-arginine oxidase in P. aeruginosa, this possibility was further 
explored by growth phenotype analysis of knockout mutants. As described in Materials 
and Methods, inactivated PA1416 and PA1417 genes carrying a tetracycline-resistant 
cassette were introduced by conjugation and homologous recombination to an aruF 
mutant, devoid of the first enzyme of the AST pathway (Table 1.1). Growth of the aruF 
mutant on L-arginine as the sole source of carbon and nitrogen was retarded, as 
evidenced by a longer generation time than that of the wild type PAO1 (220 min versus 
75 min). Disruption of PA1416 or PA1417 in the aruF mutant, however, exerted no 
significant effect on L-arginine utilization, while in contrast disruption of gbuA abolished 
growth on L-arginine. These results did not support the hypothesis that PA1416 and 
PA1417 participate in the ADH pathway. 
 
 
 
 24
1.3.4 The dadAX locus.  
While the presence of an L-arginine oxidase activity was reported in P. putida, this 
enzymatic activity has never been demonstrated in P. aeruginosa. Instead, a specific D-
arginine inducible D-arginine dehydrogenase was reported in P. aeruginosa PAO1 (Jann 
et al., 1988), leading Jann and Haas to propose an alternative route for the ADH pathway 
involving this enzyme and an arginine racemase (Fig. 1.1). The current genome 
annotations (www.pseudomonas.com) designated PA5304 and PA5302 as dadA and 
dadX (Table 1.2) based on the amino acid sequence similarity of the encoded proteins to 
the catabolic D-alanine dehydrogenase and the alanine racemase of E. coli (Strych et al., 
2000), respectively. Since these two genes were induced by L-arginine, experiments were 
conducted to test the hypothesis that they might encode the D-arginine dehydrogenase 
and arginine racemase. 
The effect of L-alanine, L-arginine and D-arginine on dadAX expression was studied 
by measurements of β-galactosidase activities from the wild types strain PAO1 harboring 
a dadA::lacZ fusion plasmid, pZY6. It was found that the promoter activity of dadA on 
plasmid pZY6 was induced by L-alanine (950 µmol/min/mg) rather than by D-arginine 
(52 µmol/min/mg) or by L-arginine (36 µmol/min/mg). L-Arginine, however, did exert a 
moderate induction effect on the dadA promoter in the argR (121 µmol/min/mg) or aruF 
(212 µmol/min/mg) mutant. In contrast, D-arginine only slightly induced the promoter 
activity of dadA (88 µmol/min/mg), thus suggesting that DadAX might not be directly 
involved in arginine catabolism. 
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To investigate the role of DadA in arginine catabolism, dadA knockout mutants were 
constructed in the wild type strain PAO1 or its aruF mutant. Disruption of dadA only 
resulted in negligible decrease of D-arginine dehydrogenase activity. However, the dadA 
aruF double mutant did not show growth (Table 1.5), while the dadA mutant grew well, 
on L-arginine as the sole source of carbon and nitrogen. 
These results would be those expected if, according to the gene annotations, the 
dadAX genes encode a dehydrogenase and a racemase for alanine, but not for arginine. A 
moderate level of induction effect by L-arginine to dadAX in an aruF mutant and the 
abolishment of arginine utilization in a dadA aruF mutant would suggest a possibility 
that the intracellular alanine pool was increased when L-arginine was supplemented to 
the growth of the aruF mutant. Alanine could be a side product of arginine utilization via 
an alternative pathway when the AST pathway is not available. However, none of the 
proposed reactions in the ADH pathway would make alanine. It led us to propose that an 
arginine:pyruvate transaminase, instead of arginine dehydrogenase or oxidase, catalyzes 
the removal of α-amino group from L-arginine and makes alanine with pyruvate as the 
amino group acceptor.  
 
1.3.5 The aruIH locus.  
As shown in Table 1.2, the contiguous PA4981-PA4975 genes were coordinately 
induced to a high level by L-arginine in the argR mutant. Among these genes, PA4976 
and PA4977 encode a putative class-I transaminase and thiamine pyrophosphate-
dependent decarboxylase, respectively. They could serve to catalyze the first two steps of 
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our newly proposed arginine transaminase pathway. Knockout mutants of these seven 
genes were constructed in an aruF mutant as described in Materials and Methods, and the 
growth phenotype of these mutants on L-arginine was determined. The results showed 
that disruption of PA4976 or PA4977 in the aruF mutant abolished the growth on L-
arginine as the sole source of carbon and nitrogen, and it showed no effect on glutamate 
utilization. The effect of PA4976 and PA4977 on L-arginine utilization was only 
observed in the aruF mutant but not in the wild type strain PAO1, thus suggesting the 
enzymes encoded by those two genes might be directly involved in L-arginine utilization 
when the AST pathway was blocked. PA4976 and PA4977 were designated as aruH and 
aruI (arginine utilization) in accordance with their possible physiological functions. 
Other genes in this locus encode proteins for energy metabolism (PA4975), lipid 
metabolism (PA4980-PA4978) and amino acid transport (PA4981) as suggested by 
genome annotations (Table 1.2). Except PA4979 encoding a putative acyl-CoA 
dehydrogenase, the mutants of these genes in this locus grew on L-arginine indifferent 
from the parent strain. It was noted that the lipAH operon encoding a lipase and a lipase 
modulator was also induced by L-arginine in the argR mutant (Tables 1.2 & 1.3). These 
results suggested an interesting link between L-arginine and lipid metabolism with 
unknown physiological significance. 
Expression of the aruIH genes could be from an L-arginine-inducible promoter 
immediately upstream of PA4980 as demonstrated in Table 1.3. With no apparent rho-
independent terminator structure on the nucleotide sequence of this region, it is likely that 
this detected promoter of PA4980 could serve to make a polycistronic transcript for 
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PA4980 to PA4975. In contrast, a rho-independent terminator was identified immediately 
after the 3’-end of PA4981 coding sequence in the PA4981-PA4980 intergenic region. It 
suggested the presence of another promoter for PA4981 yet to be identified. 
The transposon used in construction of these mutants does not have any 
transcriptional terminator structures at the flanking regions. Insertion of such a 
transposon was not expected to have a polar effect on the expression of downstream 
genes. Complementation by pZY9 carrying aruH only restored growth on L-arginine in 
the aruF aruH mutant, but not the aruF aruI mutant. These results supported that 
transposon insertion at aruI did not exert a polar effect on the downstream aruH gene, 
and that both aruH and aruI were related to L-arginine utilization 
 
1.3.6 AruH is an L-arginine:pyruvate transaminase.  
Enzymatic measurements as described in Materials and Methods were conducted to 
demonstrate the proposed L-arginine:pyruvate transaminase (ATase) activity of AruH. To 
ensure that the production of alanine was from the transamination reaction between L-
arginine and pyruvate, we used the blanks which did not contain L-arginine, pyruvate or 
crude extract. As shown in Table 1.4, an L-arginine inducible ATase activity was 
detected in the aruF mutant when pyruvate was used as the amino group acceptor in the 
reaction. This ATase activity was abolished when an aruH knockout was introduced to 
the strain. While the ATase activity was induced at least 76 fold by L-arginine in the 
aruF mutant, no arginine induction of this enzyme can be observed in the wild type strain 
PAO1. These results supported the proposed biochemical function of AruH and its 
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potential role in the ATA pathway as the second arginine catabolic pathway under 
aerobic conditions. Detailed characterization of AruH was reported in Chapter Two 
(Yang and Lu, 2007a). 
 
1.3.7 AruI encodes a 2-ketoarginine decarboxylase.  
Based on the results of sequence and growth phenotype analyses, we proposed that 
AruI encodes a 2-ketoarginine decarboxylase catalyzing the second step of the ATA 
pathway. To test this hypothesis, we set up the proposed decarboxylation reaction as 
described in Materials and Methods with crude extracts of the aruF and aruF aruI 
mutants grown in the minimal medium with glutamate and arginine as the carbon and 
nitrogen sources, and the reaction components were analyzed by HPLC. As demonstrated 
in Fig. 1.2, with the crude extract of the aruF mutant, consumption of 2-ketoarginine was 
accompanied by generation of a new compound, presumably 4-guanidinobutyraldehyde 
(GUBAL); more than 85% of 2-ketoarginine was converted into GUBAL in the reaction. 
In contrast, only about 15% of substrate consumption was observed under the same assay 
conditions with cell extract of the aruF aruI mutant. These results support our hypothesis 
that AruI encodes a 2-ketoarginine decarboxylase. 
 
1.3.8 Regulation of the ATA pathway by the AruRS two-component system.  
The observation that genes listed in Table 2 were induced by exogenous L-arginine in 
the argR mutant strongly suggested the presence of another arginine-responsive 
regulatory system. Genes PA4982 and PA4983 encoding a sensor and a response 
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regulator of a putative two-component system were located immediately upstream of the 
aruIH locus. To investigate the potential role of this two-component system in regulation 
of genes in the aruIH locus, knockout mutants of PA4982 and PA4983 were constructed, 
and expression of the PA4980::lacZ fusion in the resulting mutants were analyzed by 
measurements of β-galactosidase activities. As shown in Table 3, while L-arginine 
exerted 5.8-fold and 17.8-fold of induction on the PA4980 promoter in wild type strain 
and the argR mutant, respectively, this induction effect was abolished when either 
PA4983 or PA4982 was disrupted regardless of ArgR. We therefore designated these two 
genes as aruS (PA4982) and aruR (PA4983). 
The effect of aruRS in arginine utilization was also studied by growth phenotype 
analysis. It was found that disruption of either aruS or aruR in the aruF mutant prevented 
growth on L-arginine. Furthermore, the arginine transaminase activities showed no 
induction by L-arginine in the aruR mutant and a marginal induction in the aruS mutant 
(Table 1.4). Similarly, the levels of kauB and gbuA promoter activities in these two 
mutants were significantly reduced in the presence of L-arginine (Table 1.3). These 
results demonstrated the essential role of AruRS in regulation of arginine transaminase 
synthesis, hence the ATA pathway, in response to exogenous L-arginine. 
 
1.3.9 Repression of the aruIH (PA4980) promoter activity by the addition of 
succinate as a carbon source. 
P. aeruginosa are well known for its metabolic versatility, which offers this organism 
an extraordinary ability to utilize a wide range of organic compounds as carbon and/or 
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nitrogen sources. In P. aeruginosa, expression of enzymes for the catabolic pathways of 
these compounds is subjected to carbon catabolite repression (CCR), although the 
mechanism is still unknown. Different from what is known in Escherichia coli and 
Bacillus subtilis, glucose does not play the central role in CCR in P. aeruginosa. In 
contrast, this organism preferentially metabolizes the tricarboxylic acid cycle 
intermediates rather than other carbon sources. It has been reported that in P aeruginosa 
the presence of succinate could repress the expression of enzymes of catabolic pathways 
for various carbon sources including glucose and arginine. 
Since genes of the aruIH locus are related to arginine catabolism, we tested whether 
the expression of those genes also fell into CCR. The effect of succinate on the 
expression of PA4980 promoter was analyzed by measurements of β-galactosidase 
activities in P. aeruginosa PAO1 harboring the recombinant plasmids pZY5. As shown in 
Table 1.6, while β-galactosidase expression from this PA4980::lacZ translational fusion 
was induced when L-arginine served as a sole source of carbon and nitrogen, this 
induction effect was strongly repressed (14.5 fold) when succinate was present in the 
medium. In contrast, no significant change was observed in the addition of ammonium.  
 
1.3.10 The effects of other amino acids on the promoter activity of the aruIH locus.  
We found that expression of the aruIH genes could be from an L-arginine-inducible 
promoter immediately upstream of PA4980. Also, we demonstrated that AruRS two-
component regulatory system is essential for aruHI induction by L-arginine. We 
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therefore thought that the regulation of the aruIH locus was likely to be arginine-specific, 
although we do not know whether L-arginine per se is the induction signal of AruRS. 
As shown in Chapter Two (Yang and Lu, 2007a), further characterization of AruH 
showed that while L-arginine was found to be the best substrate among these amino 
acids, this transaminase also exhibited the catalytic activity with less efficiency toward L-
lysine, L-methionine, L-leucine and ornithine. This result suggested that expression of the 
aruIH genes might also be induced by those amino acids. To test this hypothesis, 
expression of the PA4980::lacZ fusion was analyzed in P. aeruginosa strains PAO1 and 
PA4558 by measurements of β-galactosidase activities. As shown in Table 1.7, ornithine 
exerted 13.3-fold and 100.8-fold of induction on the PA4980 promoter in wild type strain 
and its argF mutant, respectively. This was similar to what observed for L-arginine as we 
expected because arginine and ornithine have very similar chemical structure. It was 
noted that while lysine exerted 25.4-fold of induction on the PA4980 promoter in wild 
type strain, this induction effect was not observed in the aruF mutant. We do not know 
why the PA4980 promoter was induced by exogenous lysine in wild type strain and the 
mechanism by which lysine induction effect was abolished in the aruF mutant. These 
results suggested an interesting link between the genes of the aruIH locus and L-lysine 
metabolism with unknown physiological significance.  
 
1.4 DISCUSSION 
    Three lines of evidence that arose from this study led us to conclude that the ATA 
pathway, instead of the ADH pathway, is the second pathway for L-arginine utilization in 
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P. aeruginosa under aerobic conditions. Firstly, an L-arginine-inducible ATA was 
encoded by the newly identified aruH gene. Secondly, disruption of aruH in a strain 
devoid of a functional AST pathway abolished the ability of the resulting strain to utilize 
L-arginine as the sole source of carbon and nitrogen. Thirdly, AruH utilizes pyruvate as 
the amino group acceptor, and hence makes alanine, in the transamination reaction. 
Recycling of pyruvate through the catabolic alanine dehydrogenase DadA is essential for 
arginine utilization in the ATA pathway, as supported by the observation that the aruF 
dadA mutant cannot grow on L-arginine as the sole carbon source. It is likely that in this 
mutant, accumulation of alanine without recycling of pyruvate would drain the 
intracellular pool of pyruvate and thus the carbon source provided by L-arginine through 
the ATA pathway. 
While no L-arginine dehydrogenase or oxidase activity has ever been demonstrated in 
P. aeruginosa, the results of a previous study also did not favor the presence of an ATA. 
It was based on the observation that arginine auxotrophs were not complemented by 2-
KA in the presence of L-alanine, assuming that L-arginine would be generated by these 
two substrates in the reverse reaction of arginine transamination. It was very likely that 
the proposed reverse reaction never happened, for the following reasons. The ATA may 
not be expressed in the arginine auxotrophs in the absence of arginine. Even if the 
enzyme were expressed, 2-KA and L-alanine might not be available at a concentration 
high enough to drive the reverse reaction. Alanine could induce the expression of DadX 
and DadA and thus be converted into pyruvate. Also, it has been reported in the same 
study that 2-KA induced GbuA, suggesting catabolism of 2-KA into 4-guanidinobutyrate 
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(Nakada and Itoh, 2002). In addition, as reported in Chapter Two (Yang and Lu, 2007a), 
no L-arginine synthesis can be detected by HPLC in the reverse reaction with purified 
AruH under the assay conditions used. 
In comparison, the AST pathway is more efficient than the ATA pathway in many 
aspects. First, it is more efficient in terms of L-arginine affinity. The Km of L-arginine is 
0.5 mM to AST AruF (Tricot et al., 1991) and 14 mM to ATA AruH (Itoh, 1997). 
Second, it is more efficient in terms of gene organization and regulation. The genes that 
encode enzymes of the AST pathway are organized into the aru operon and the gdhB 
gene, and they are controlled by a single regulator, ArgR. Genes of the ATA pathway are 
most likely grouped into several regulatory modules in response to different intermediate 
compounds that were also involved in polyamine catabolism (Haas, 1990). We found in 
this study that the AruRS two-component regulatory system is essential for aruHI 
induction by L-arginine; however, whether L-arginine per se is the induction signal of 
AruRS remained to be elucidated. Without a functional ArgR protein, it is known that the 
AST pathway and L-arginine uptake would be severely hampered. It has been reported 
that blocking of the AST pathway alone is sufficient to render enzymes of the ATA 
pathway inducible by L-arginine (Itoh, 2004; Jann et al., 1988). Perhaps N2-succinyl-L-
arginine or its derivatives of the AST pathway might serve as an antagonistic signal to 
block the AruRS system, and subsequently expression of the less efficient ATA pathway, 
when the AST pathway is available. 
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The kauB and gbuA genes of the ATA pathway could be controlled by a regulatory 
module different from ArgR and AruRS. The gbuA gene has been reported to be 
regulated by GbuR, a transcriptional activator of the LysR family, in the presence of 4-
guanidinobutyrate (Nakada and Itoh, 2003). It was still not clear how kauB was regulated, 
as this gene encodes a bifunctional enzyme in the ADC and ATA pathways (Jann et al., 
1988). As mentioned earlier, putrescine and spermidine exerted a stronger induction 
effect on the expression of kauB than L-arginine. It was possible that a common 
regulatory mechanism could be shared by kauB and other genes involved in polyamine 
metabolism. 
The gene organization of the aruHI locus in P. aeruginosa PAO1 was found to be 
highly conserved in P. putida KT2440 and Pseudomonas fluorescens Pf-1, as shown in 
Fig. 1.3. Given the proven functions of AruIH in the ATA pathway of P. aeruginosa and 
the conserved gene organization, it is very likely that the ATA pathway also contributes 
to L-arginine utilization in P. fluorescens and P. putida. Although an L-arginine oxidase 
activity has been reported in P. putida P2 (Chou and Rodwell, 1972; Vanderbilt et al., 
1975), we were unable to detect this enzyme activity in P. putida KT2440. However, it 
was noted that the reading frame of P. putida AruI was interrupted by a termination 
codon in its coding sequence. Furthermore, PP3722, which encodes a putative amino acid 
racemase, was located between aruI and aruH in this organism. More work is required to 
answer the question of 2-KA synthesis in P. putida. 
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As evidenced in Chapter Two (Yang and Lu, 2007a), we concluded that AruH is not 
the homologue of E. coli AspC (Fotheringham et al., 1986), an aspartate transaminase for 
aspartate biosynthesis, as was initially described in the Pseudomonas genome annotation. 
With E. coli AspC as the template to search against the PAO1 genome, the results of a 
BLAST search showed that PA3139 and PA0870 are the two most prominent candidates. 
However, PA0870 was annotated as PhhC, which has been reported as an essential 
transaminase for tyrosine and phenylalanine catabolism (Stover et al., 2000). Therefore, it 
is likely that PA3139 is the biosynthetic aspartate transaminase. Similarly, the AruI 
protein was demonstrated by HPLC analysis in this study to catalyze the decarboxylation 
reaction of 2-KA in the ATA pathway and is not likely the homologue of E. coli 
acetolactate synthase IlvB (Friden et al., 1985), as suggested by genome annotation. 
Instead, PA4696 is the most likely candidate on the basis of its 77% sequence similarity 
to E. coli IlvB. Moreover, it was noted that AruI exhibited 57% similarity to another 
putative TPP-dependent decarboxylase encoded by PA1417, which was also identified in 
this study as a gene inducible by L-arginine in the absence of ArgR. While the 
physiological function of PA1417 remained unknown, it was intriguing to speculate that 
it might be responsible for the observed residual 2-KA decarboxylase activity in the aruF 
aruI mutant (Fig. 1.2). 
In this study, we have ruled out the significance of D-arginine-inducible D-arginine 
dehydrogenase (Jann et al., 1988) in L-arginine utilization; however, this yet-to-be-
identified enzyme could still provide an alternative route for D-arginine utilization. We 
have observed that D-arginine utilization was partially retarded in the aruF mutant devoid 
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of the AST pathway, and blocking of the ATA pathway in this mutant by either aruH or 
aruI did not result in further inhibition of growth on D-arginine. To be utilized by the 
AST pathway, D-arginine is supposed to be converted into L-arginine by a racemase, as 
D-arginine is a competitive inhibitor of AST catalyzing the first reaction of the AST 
pathway (Tricot et al., 1991). The physiological functions of arginine racemase and D-
arginine dehydrogenase in arginine metabolism warrant further investigation. 
In conclusion, the complexity of arginine metabolism in P. aeruginosa was fully 
illustrated in our previous report (Lu et al., 2004) and in this study employing DNA 
microarray analyses. While some of these discoveries have apparent linkages to arginine 
metabolism, many of the newly identified avenues remained interesting topics to explore. 
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TABLE 1.1. Bacterial strains and plasmids used in this study. 
Strain or plasmid Genotype or descriptiona Source or  
Reference 
Strains   
E. coli   
DH5α F  80dlac M15 (lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rK  mK ) supE44 thi-1 gyrA96 relA1 
Bethesda Research 
Laboratories 
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu (Kmr)  
   
P. aeruginosa   
PAO1 Wild type  
PAO501 argR::Gm  
PAO1-Sm Spontaneous Smr of PAO1  
PAO4558 aruF  
PAO4558-Sm Spontaneous Smr of PAO4558 This study 
PAO4566 aruF gbuA This study 
PAO5508 aruS::Tc This study 
PAO5509 aruR::Tc This study 
PAO5601 PA4975::Tc aruF This study 
PAO5602 aruH::Tc aruF This study 
PAO5603 aruI::Tc aruF This study 
PAO5604 PA4978::Tc aruF This study 
PAO5605 PA4979::Tc aruF This study 
PAO5606 PA4980::Tc aruF This study 
PAO5607 PA4981::Tc aruF This study 
PAO5608 aruS::Tc aruF This study 
PAO5609 aruR::Tc aruF This study 
PAO5610 dadA::Tc aruF This study 
PAO5018 aruS::Tc argR::Gm This study 
PAO5019 aruR::Tc argR::Gm This study 
   
Plasmids   
pQF50 bla lacZ transcriptional fusion vector  
pQF52 bla lacZ translational fusion vector  
pRTP1 Apr Strs conjugation vector  
pUCP18 E. coli-P. aeruginosa shuttle vector  
pZY1 gbuA::lacZ translational fusion of pQF52 This study 
pZY2 lipA::lacZ translational fusion of pQF52 This study 
pZY4 PA3865::lacZ translational fusion of pQF52 This study 
pZY5 PA4980::lacZ translational fusion of pQF52 This study 
pZY6 dadA::lacZ translational fusion of pQF52 This study 
pZY7 kauB::lacZ transcriptional fusion of pQF50 This study 
pZY8 PA5313::lacZ transcriptional fusion of pQF50 This study 
pZY9 An aruI PA4975 clone in pUCP18 This study 
pMO012222 Cosmid clone containing PA1415-PA1417 gene cluster in 
pLA2917; Tcr 
 
pMO012227 Cosmid clone containing aruRS-aruH gene cluster in pLA2917; 
Tcr
 
pMO011841 Cosmid clone containing dadA gene in pLA2917; Tcr  
 
aGm, gentamicin; Sm, streptomycin; Tc, tetracycline; Km, kanamycin. 
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TABLE 1.2. Microarray analysis of genes induced by L-arginine in the absence of ArgR 
in P. aeruginosa. 
 
Absolute signal valuebGene no.a Gene name Protein description PAO1 (E) PAO1 (ER) PAO501 (ER) 
*PA0265 gabD Succinate-semialdehyde dehydrogenase 332 707 4,227 
*PA0266 gabT 4-Aminobutyrate aminotransferase 712 1,192 5,606 
*PA0296 spuI Glutamine synthetase homologue 1,018 1,301 4,505 
*PA0297 spuA Glutamine amidotransferase 186 687 2,866 
*PA0298 spuB Glutamine synthetase homologue 514 1,166 3,872 
*PA0299 spuC Putrescine aminotransferase 869 1,902 5,620 
PA1415  Unknown 118 131 946 
PA1416  FAD linked oxidase 49 11 377 
PA1417  Decarboxylase 68 149 531 
PA1418  Transport of small molecules 152 128 1,748 
PA1419  Transport of small molecules 43 72 1,015 
PA1420  Unknown 47 151 1,357 
PA1421 gbuA Guanidinobutyrase 66 46 954 
PA2310  Unknown 68 114 579 
PA2311  Unknown 525 1,379 8,153 
PA2312  Transcriptional regulator 150 339 1,424 
PA2313  Unknown 70 87 190 
PA2862 lipA Lactonizing lipase precursor 760 451 3,871 
PA2863 lipH Lipase modulator protein 127 77 606 
PA3690  Metal transporting P-type ATPase 162 426 8,550 
PA3862  Unknown 84 245 772 
PA3863  Unknown 56 265 602 
PA3864  Unknown 257 418 953 
PA3865  Amino acid binding protein 174 498 3,558 
PA4975  NAD(P)H quinone oxidoreductase 98 225 2,635 
PA4976 aruH Arginine: pyruvate transaminase 61 192 2,639 
PA4977 aruI 2-Ketoarginine decarboxylase 59 149 3,977 
PA4978  Pimeloyl-CoA synthetase 69 177 2,998 
PA4979  Acyl-CoA dehydrogenase 77 17 3,435 
PA4980  Enoyl-CoA hydratase/isomerase 97 687 7,154 
PA4981  Transport of small molecules 57 573 12,235 
*PA5302 dadX Alanine racemase 26 85 408 
*PA5303  Unknown 81 162 571 
*PA5304 dadA D-Alanine dehydrogenase 88 113 643 
*PA5309  Oxidoreductase 413 651 1,878 
*PA5312 kauB 4-Guanidinobutyraldehyde dehydrogenase 780 1,111 4,774 
*PA5313  Pyridoxal-dependent aminotransferase 150 386 1,449 
*PA5314  Unknown 123 397 1,646 
  PA3537 argF Ornithine carbamoyltransferase 874 181 1,444 
  PA0896 aruF Arginine succinyltransferase 174 4,054 59 
 
a Gene numbers are from the Pseudomonas Genome Project (www.pseudomonas.com). 
Genes that were also induced by agmatine, putrescine and spermidine were marked with 
asterisks. The expression profiles of argF and aruF at the end of this list represented 
ArgR-dependent repression and activation, respectively. 
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b Abbreviations: E, cells were grown in glutamate minimal medium P (MMP); ER, cells 
were grown in glutamate MMP supplied with 20 mM L-arginine. 
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TABLE 1.3. Verification of microarray data by promoter-lacZ fusions. 
 
Sp act (µmol/min/mg)b Fold changecGene no. 
(name)a Host strain (genotype) Glu Glu+Arg  
PA1421 (gbuA) PAO1 (wild type) 9 18 2.0 
 PAO501 (argR) 7 216 30.9 
 PAO4558 (aruF) 11 177 16.1 
 PAO5608 (aruF, aruS) 9  26 2.9 
 PAO5609 (aruF, aruR) 12 37 3.1 
     
PA2862 (lipA) PAO1 (wild type) 107 68 0.6 
 PAO501 (argR) 251 963 3.8 
     
PA3865 PAO1 (wild type) 823 208 0.3 
 PAO501 (argR) 664 2,156 3.2 
     
PA4980 PAO1 (wild type) 1,241 7,216 5.8 
 PAO501 (argR) 1,643 29,191 17.8 
 PAO5508 (aruS) 1,069 998 0.9 
 PAO5509 (aruR) 251 355 1.4 
 PAO5018 (argR aruS) 1,158 2,217 1.9 
 PAO5019 (argR aruR) 942 824 0.9 
 PAO4558 (aruF) 145 22,899 157.9 
 PA5608 (aruF aruS) 177 1,547 8.7 
 PAO5609 (aruF aruR) 101 635 6.3 
     
PA5304 (dadA) PAO1 (wild type) 30 36 1.2 
 PAO501 (argR) 47 121 2.6 
     
PA5312 (kauB) PAO1 (wild type) 111 136 1.2 
 PAO501 (argR) 116 266 2.3 
 PAO4558 (aruF) 102 234 2.3 
 PAO5608 (aruF aruS) 9 21 2.3 
 PAO5609 (aruF aruR) 4 12 3 
     
PA5313 PAO1 (wild type) 254 335 1.3 
 PAO501 (argR) 178 677 3.8 
 
a Gene numbers and names are from the Pseudomonas Genome Project 
(www.pseudomonas.com). 
b Specific activities are average of three measurements for each growth condition, with 
standard errors of less than 5%. Glu, cells were grown in glutamate minimal medium P 
(MMP); Glu+Arg, cells were grown in glutamate MMP supplied with 20 mM L-arginine. 
c Fold changes of gene expression are indicated by the ratio of cells grown in glutamate 
MMP in the presence of arginine to cells grown in glutamate MMP in the absence of 
arginine. 
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TABLE 1.4. Measurements of L-arginine transaminase activities in P. aeruginosa PAO1 
and its mutant strains. 
 
Sp acta (nmol/min/mg) Strains (Genotype) Glu Glu + Arg 
PAO1 (wild type) <0.5 <0.5 
PAO4558 (aruF) <0.5 38 
PA5602 (aruH aruF) <0.5 <0.5 
PA5608 (aruS aruF) <0.5 3 
PA5609 (aruR aruF) <0.5 <0.5 
 
a Cells were cultured to mid-log phase (OD600 = 0.5) in MMP-glutamate medium with or 
without L-arginine. Cell extracts preparation and the enzyme assays were described in 
Materials and Methods. 
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TABLE 1.5. Growth of P. aeruginosa PAO1 and its mutant strains on L-arginine. 
 
Strain Genotype Doubling time (min)a
PAO1 Wild type 75 
PAO501 argR 295 
PAO4558 aruF 221 
PAO4562 aruF aguAB 275 
PAO4566 aruF gbuA NG 
PAO5602 aruF aruH  NG 
PAO5603 aruF aruI  NG 
PAO5605 aruF PA4979  NG 
PAO5608 aruF aruS NG 
PAO5609 aruF aruR  NG 
PAO5610 aruF dadA  NG 
a Cell growth was tested in MMP containing 20mM L-arginine as sole carbon and 
nitrogen sources.  NG, no growth. 
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TABLE 1.6. Measurements of β-galactosidase activity in P. aeruginosa strains PAO1 
harboring PA4980::lacZ translational fusion plasmid pZY5. 
 
Growth conditionsa Sp act (monomers/103 cells)b
Suc+NH4+ 1.1 
Suc+Arg 1.5 
Arg+NH4+ 19.4 
Arg 21.7 
 
a Abbreviations: Arg, cells were grown in arginine minimal medium P (MMP); Suc+Arg, 
cells were grown in arginine MMP supplied with 20 mM succinate; Arg+NH4+, cells 
were grown in arginine MMP supplied with 20 mM NH4Cl; Suc+NH4+, cells were grown 
in MMP supplied with 20 mM succinate and 20 mM NH4Cl. 
b Enzyme sufficient to produce 1 OD420nm per min is 4.45 x 1012 monomers. 
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TABLE 1.7. Measurements of β-galactosidase activity in P. aeruginosa strains PAO1 
and PAO4558 harboring PA4980::lacZ translational fusion plasmid pZY5. 
 
Host strains (genotypes) and growth conditionsa Sp act (µmol/min/mg) 
PAO1 (wild type)  
Glu 893 
Glu + Arg 11,963 
Glu + Lys 22,675 
Glu + Met 961 
Glu + Leu 931 
Glu + Orn 11,865 
  
PAO4558 (aruF)  
Glu 189 
Glu + Arg 25,775 
Glu + Lys 642 
Glu + Met 415 
Glu + Leu 326 
Glu + Orn 19,051 
 
a Abbreviations: Glu, cells were grown in glutamate minimal medium P (MMP); 
Glu+Arg, cells were grown in glutamate MMP supplied with 20 mM L-arginine; 
Glu+Lys, cells were grown in glutamate MMP supplied with 20 mM L-lysine; Glu+Met, 
cells were grown in glutamate MMP supplied with 20 mM L-methionine; Glu+Leu, cells 
were grown in glutamate MMP supplied with 20 mM L-leucine; Glu+Orn, cells were 
grown in glutamate MMP supplied with 20 mM L-ornithine. 
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FIG. 1.1. Arginine catabolic pathways in P. aeruginosa PAO1. Only relevant 
intermediates and genes are indicated. ADI, arginine deiminase pathway; AST, arginine 
succinyltransferase pathway; ADC, arginine decarboxylase pathway; ATA, arginine 
transaminase pathway; TCA, tricarboxylic acid. Also illustrated were two more routes for 
2-ketoarginine synthesis: arginine racemase/D-arginine dehydrogenase in P. aeruginosa 
PAO1 (ADH) and L-arginine oxidase in P. putida P2 (AO). aruF, arginine 
succinyltransferase; aruH, arginine transaminase; aruI, 2-ketoarginine decarboxylase; 
gabD, 4-aminobutyraldehyde dehydrogenase; gabT, 4-aminobutyrate transaminase; 
gbuA, 4-guanidinobutyrase; kauB, 4-guanidinobutyraldehyde/4-aminobutyraldehyde 
dehydrogenase. 
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FIG. 1.2. HPLC analysis of the AruI reaction products. Chromatograms of components of 
the reaction mixture at 205 nm either with heat-inactivated crude extracts (the aruF 
mutant, dashed gray line; the aruF aruI mutant, solid gray line) or active crude extracts  
(the aruF mutant, solid black line; the aruF aruI mutant, dashed black line) were 
recorded as described in Materials and Methods. Signal peaks for thiamine 
pyrophosphate (TPP), 2-ketoarginine (2-KA) and 4-guanidinobutyraldehyde (GUBAL) 
were individually identified, according to their same retention times as of authentic 
reference compounds. In this system, retention times for TPP, 2-KA and GUBAL were 
4.0 min, 5.9 min and 7.5 min, respectively. Traces are shown offset vertically and A205 
values are given in arbitrary units. 
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FIG. 1.3. Conserved gene organization of the aruRS-aruIH  locus in pseudomonads. Functions of the aru genes in this locus of 
P. aeruginosa were reported in this study, and the same gene designations were given to their counterparts in P. putida and P. 
fluorescens based on sequence similarities. Other genes in the locus were numbered according to each individual genome 
annotation projects. Regulatory genes are marked with filled arrows; the differences of two genes in P. aeruginosa and three 
genes in the other two species were most likely due to reading frame shift by point mutations in the nucleotide sequences. The 
additional gene 3722 of P. putida encoding a putative amino acid racemase was unique only in this organism. Also presented 
were locations of transposons carrying a tetracycline-resistance cassette (Tet) in the mutants of P. aeruginosa as described in 
the text. Open and filled triangles represent Tet in the same and reverse orientations of the inserted genes, respectively.  
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FIG 1.4. Microarray analysis of genes induced by L-arginine in the absence of ArgR in P. aeruginosa, including known genes 
of the ATA pathway (orange), putative enzyme encoding genes (grey), putative transporter genes (green) and unknown genes 
(black). Fold changes were calculated based on the absolute signal values of DNA microarray.  
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Chapter Two 
Characterization of an Arginine:Pyruvate Transaminase in Arginine Catabolism of 
Pseudomonas aeruginosa PAO1 
 
2.1 INTRODUCTION 
Arginine utilization in pseudomonads as the sole source of carbon and nitrogen can 
be mediated by multiple catabolic pathways. The arginine succinyltransferase (AST) 
pathway is the major route of arginine catabolism under aerobic conditions (Haas, 1990; 
Stalon et al., 1987). In the absence of a functional AST pathway, growth on L-arginine 
remained but was retarded (Itoh, 2004; Tricot et al., 1991). It has been reported that the 
arginine oxidase pathway is the second route of L-arginine utilization in P. putida (Miller 
and Rodwell, 1971; Tricot et al., 1991). While the arginine oxidase activity has never 
been demonstrated in P. aeruginosa, the presence of D-arginine dehydrogenase and 
arginine racemase activities provided an alternative route for L-arginine utilization by 
this organism (Jann et al., 1988). Oxidative deamination of arginine by arginine oxidase 
or dehydrogenase produces 2-ketoarginine, which is subsequently catabolized into 
succinate by a series of reactions common to both organisms. 
Synthesis of 2-ketoarginine from L-arginine can also be accomplished by the 
transamination reaction (Tachiki et al., 1980). In Chapter One (Yang and Lu, 2007b), we 
reported an arginine-inducible arginine transaminase (ATA) activity in P. aeruginosa 
PAO1, and this activity was completely abolished when the aruH gene was deleted. The 
aruH gene was proposed to encode a putative ATA residing in a multi-gene operon, 
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which is highly conserved in P. aeruginosa, P. putida, and P. fluorescens (Yang and Lu, 
2007b).  
In the present study, we purified the His-tagged AruH protein from E. coli and 
characterized its enzymatic properties. Evidence was provided herein that AruH indeed 
catalyzes a transamination reaction with pyruvate as the amino acceptor, following a 
Ping-Pong Bi Bi kinetics model. When L-arginine was used as the amino donor, the 
products of this transamination reaction, 2-ketoarginine and L-alanine, were confirmed 
by HPLC and MS, and the kinetic properties were analyzed by a coupled reaction with 
NAD+ and L-alanine dehydrogenase. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Expression of aruH in E. coli.  
The pBAD protein expression system by arabinose induction (Invitrogen) was 
employed for overproduction of AruH. The aruH structural gene was amplified by PCR 
from the genomic DNA of P. aeruginosa PAO1 using the following two primers to 
introduce an 6×His tag at the N-terminus: 5’-CCGTCATGAGACATCATCATCATCAT 
CATATGCGCTATTCCGACTTCA-3’ and 5’-AATCTGCAGTCAGGCCTGGCCGAG 
CAACTC-3’. The resulting PCR product was digested with BspHI (NcoI compatible) and 
PstI, which are unique restriction sites flanking the PCR product as introduced by the 
primers, and cloned into the NcoI and PstI sites of the expression vector pBAD-HisA. 
The resulting plasmid, pYZNH3, was introduced into E. coli Rosetta (DE3) pLysS (EMD 
Bioscience). For overexpression of aruH, the recombinant strain of E. coli was grown in 
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LB medium containing ampicillin (100 µg/ml) and chloramphenicol (30 µg/ml) at 22°C 
until the optical density at 600 nm reached 0.5, at which point 0.2% arabinose (w/v; final 
concentration) was added to the culture for induction. The culture growth was continued 
for another 18 h under the same conditions, and cells were harvested by centrifugation.  
 
2.2.2 Purification of His6-tagged AruH.  
Recombinant AruH was purified using a HisTrap HP kit (GE Healthcare) according 
to the manufacturer’s instructions. Briefly, the cell pellet (approximately 10 g) was 
suspended in 20 ml phosphate buffer (20 mM sodium phosphate, 500 mM NaCl, 20 mM 
imidazole, pH 7.4). EDTA-free protease inhibitor cocktail (2 tablets; Roche) was added, 
and the cells were ruptured by an Aminco French pressure cell at 8,000 lb/in2. The cell 
debris was removed by centrifugation at 25,000 × g for 30 min, and the resulting cell-free 
crude extract was applied onto a HisTrap HP column (GE Healthcare) equilibrated with 
the same sodium phosphate buffer as described above. After washing away the unbound 
proteins with equilibration buffer, His-tagged AruH was eluted with a stepwise gradient 
of 150 mM imidazole in 20 mM phosphate (pH 7.4) and 500 mM NaCl. For further 
purification, AruH proteins were subjected to anion exchange chromatography using a 
Mono Q HR 5/5 column (Pharmacia) equilibrated with 20 mM Tris/HCl (pH 7.4; buffer 
A). Protein sample was applied to the column and eluted with buffer A followed by a 
linear gradient of 0-1 M KCl in buffer A over 20 column volumes. Active fractions that 
were homogenous as determined by visual inspection of SDS-PAGE gels were pooled, 
and then desalted and concentrated using an Aminco Ultra-15 centrifugal filter unit 
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(molecular mass cut-off 30 kDa; Millipore). UV/visible absorption spectra of the purified 
protein (8 mg/ml) in buffer A were recorded at 25°C with a Cary 3E spectrophotometer 
(Varian). Aliquots of AruH, supplemented with 50 µM pyridoxal 5’-phosphate (PLP) and 
EDTA-free protease inhibitor cocktail, were stored at 4°C before usage for enzyme 
assays (up to 1 week storage).
 
2.2.3 Gel filtration analysis.  
Gel filtration was performed with low molecular weight (LMW) and high molecular 
weight (HMW) calibration kits (GE Healthcare), using a Superdex 200 HR 10/30 column 
(GE Healthcare) equilibrated with 50 mM sodium phosphate (pH 7.4) containing 300 
mM NaCl. The recombinant AruH (50 µl; 5 mg/ml) was injected to the column and 
eluted at a flow rate of 0.5 ml/min. Molecular mass standards used were thyroglobulin 
(669 kDa), catalase (232 kDa), aldolase (158 kDa), bovine serum albumin (67 kDa), 
ovalbumin (43 kDa) and chymotrypsinogen A (25 kDa).  
 
2.2.4 Identification of 2-ketoarginine as a product of the AruH reaction by HPLC.  
A reaction mixture (1.0 ml) containing 10 µg of recombinant AruH, 20 mM L-
arginine, 20 mM pyruvate, 0.5 mM PLP in 70 mM Tris/HCl buffer (pH 9.0) was 
incubated for 1 h at 37°C. After incubation, the sample was boiled for 10 min and then 
filtered using an Ultrafree-0.5 PBCC centrifugal filter unit (molecular mass cut-off 5 
kDa; Millipore). In a negative control experiment, heat-denatured recombinant AruH was 
used to prepare the reaction mixture. Reaction samples were separated on a Breeze HPLC 
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system (Waters) equipped with a Develosil RP-Aqueous C30 column (4.6 × 250 mm; 
Phenomenex) at a flow rate of 1 ml/min. The mobile phase was 0.1 M potassium 
phosphate (pH 2.0), and elution was monitored by UV detection at 205 nm. Authentic L-
arginine, pyruvate, PLP and 2-ketoarginine were used as standards. A protocol described 
by Jann et al (Jann et al., 1988) was followed to prepare 2-ketoarginine. 
For the reversible reaction, 20 mM 2-ketoarginine and 20 mM L-alanine were used as 
substrates to replace 20 mM L-arginine and 20 mM pyruvate using the same method as 
described above, followed by HPLC analysis.  
 
2.2.5 Mass spectrometry of the AruH reaction products.  
Samples prepared as described above for HPLC analysis were submitted for 
electrospray ionization mass spectrometry (ESI-MS) analysis in Mass Spectrometry 
Facility at Georgia State University. In the L-lysine experiments, 20 mM L-lysine was 
used to replace 20 mM L-arginine as the amino donor. The samples were diluted with 
MeOH (1:1, v/v) and introduced to a Q-Tof micro MS (Waters) for analysis using 
negative mode by infusion injection at flow rate of 5 µl/min, with a capillary voltage of 
3.5 kV, a sample cone voltage of 25 V and an extract cone voltage of 1.0 V. 
 
2.2.6 Enzyme assays.  
The arginine:pyruvate transaminase activity of the recombinant AruH was measured 
in two steps. The first step was a transamination reaction catalyzed by recombinant 
AruH, in which α-amino group of L-arginine was transferred to pyruvate, making 
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therefore 2-ketoarginine and L-alanine. In the second step, the amounts of L-alanine 
formed in the transamination reaction were determined using an enzyme coupled reaction 
as previously described (Yang and Lu, 2007b), in which L-alanine was oxidized to 
pyruvate and ammonia in the presence of NAD+ and L-alanine dehydrogenase. 
Briefly, the assay mixture I (1.0 ml; final volume) contained 20 mM L-arginine, 20 
mM pyruvate, 0.5 mM PLP and 70 mM Tris/HCl (pH 9.0), unless otherwise noted. The 
assay mixture I was pre-incubated for 10 min at 37°C prior to the addition of 10 µg of 
recombinant AruH by which the reaction was started. A 4-min incubation period at 37°C 
consumed <10% of the substrates. The reaction was stopped by the addition of 50 µl 
anhydrous hydrazine (Sigma) which trapped the remaining substrate pyruvate (also 
reaction product 2-ketoarginine) as the hydrazones. The protein precipitates were 
removed by centrifugation after the assay mixture I was boiled for 10 min. Blanks did not 
contain L-arginine, pyruvate or recombinant AruH. The reaction I was linear with 
incubation of assay mixture up to 5 minutes and enzyme concentration up to 20 µg/ml. 
For the second step, the assay mixture II (2.1 ml) contained 1ml hydrazine/Tris buffer 
(hydrazine, 1.0 M; Tris base, 40 mM; EDTA, 1.4 mM; adjusted to pH 9.0 with HCl), 1.2 
mM NAD+ and supernatant from reaction I (0.1-0.8 ml containing 10-100 µM L-alanine). 
The assay reaction II was started by the addition of 2 units of L-alanine dehydrogenase 
(Sigma), and the increase of the absorbance at 339 nm was monitored at 25°C until no 
significant increase could be detected. The molar extinction coefficient (6300 M-1cm-1) of 
NADH was used for the calculation. One unit of enzyme activity is defined as the amount 
of the enzyme that yielded 1 µmol of L-alanine per min under the standard assay 
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conditions as described above. The reaction II with L-alanine dehydrogenase is specific 
for L-alanine determination and linear over the range of 5-300 µM L-alanine 
(Williamson, 1985). The protein concentration was determined by the method of 
Bradford (Bradford, 1976) with bovine serum albumin as the standard.  
    
2.2.7 Kinetic studies.  
Kinetic assays were performed using the two-step assay method as described above 
with various concentrations of L-arginine (the amino donor, 2.0-10.0 mM) and pyruvate 
(the amino acceptor, 0.3-2.0 mM). Using the kinetics module of SigmaPlot (SigmaPlot 
2004 for Windows Version 9.01, SPSS Science), apparent kinetic parameters were 
determined by fitting data to the equations for sequential and ping-pong steady state 
mechanisms, respectively. 
 
2.2.8 Substrate specificity.  
Substrate specificity was investigated by the same assay method as described above, 
replacing 20 mM of L-arginine with various L-amino acids as the amino donor or 
replacing 20 mM pyruvate with 20 mM 2-ketoglutarate as the amino acceptor. When 2-
ketoglutarate was used as the amino acceptor in the reaction, synthesis of L-glutamate 
was measured by monitoring the formation of NADH from NAD+ in a coupled reaction 
with L-glutamate dehydrogenase (Beutler, 1985). Anhydrous hydrazine (Sigma) was 
used to trap remaining substrate 2-ketoglutarate, similar to that used for the 
arginine:pyruvate transaminase assay.  
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2.2.9 pH and temperature studies.  
For the pH studies, 70 mM of potassium phosphate (pH 6.0-8.0), Tris/HCl (pH 7.4-
9.5) and borate/NaOH (9.0-10.0) buffers were used in the assay. Similarly, the 
temperature dependence of AruH activity was evaluated by incubating the assay mixture 
I for 4 min at 25-50°C. 
 
2.3 RESULTS 
2.3.1 Overproduction and purification of recombinant AruH.  
The pBAD system was employed for over-expression of the recombinant AruH in E. 
coli. However, initial attempts encountered two difficulties: low expression level and 
formation of inclusion bodies. We have successfully overcome these problems by 
integrating several features in the final recombinant strain. As described in Materials and 
Methods, the aruH gene was cloned into the expression vector pBAD-HisA using the 
strategy that allowed the N-terminus of AruH to fuse directly with a His6 tag rather than 
through a linker region to minimize interference to the folding or bioactivity of 
recombinant proteins. The resulting plasmid pYZNH3 was expressed at 22°C to reduce 
the formation of inclusion bodies in the E. coli Rosetta (DE3), which has been proven to 
be useful to overcome the codon bias problem. With these modifications, the His-tagged 
AruH was expressed well and became soluble. After two steps of column 
chromatography (affinity and anion exchange), the recombinant AruH protein was 
purified to homogeneity as evidenced by SDS-PAGE (Fig. 2.1).  
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2.3.2 Molecular mass and absorption spectrum.  
As shown in Fig. 2.1, a value of 43 kDa for the molecular mass of the AruH was 
determined from a plot of electrophoretic mobility against the logarithm of the molecular 
masses of known polypeptides. The results of gel filtration column chromatography 
revealed an apparent molecular mass of 79.3 kDa for native enzymes (Fig. 2.2), 
indicating that the His-tagged AruH is a homo-dimer. 
The purified AruH proteins had a distinct yellow color, suggesting the presence of a 
bound chromophore. As demonstrated below, AruH possessed a PLP-dependent 
transamination activity. UV/VIS spectroscopic analysis of AruH revealed an absorption 
peak centered at 425 nm (Fig. 2.9), consistent with the presence of PLP.  
 
2.3.3 Assay of a PLP-dependent arginine:pyruvate transaminase activity of AruH.   
As described in Chapter One (Yang and Lu, 2007b), several lines of genetic and 
biochemical evidences led us to propose that AruH possesses an arginine:pyruvate 
transaminase activity. In this reaction, L-arginine and pyruvate served as the amino donor 
and acceptor, respectively, to make 2-ketoarginine and L-alanine. The amount of L-
alanine thus synthesized was measured by the generation of NADH in a coupled reaction 
by a NAD-dependent L-alanine dehydrogenase as described in Materials and Methods. 
With this assay, it was found that only negligible L-alanine production could be detected 
in the absence of PLP, indicating that AruH is a PLP-dependent enzyme. 
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HPLC and MS analyses were employed to demonstrate the generation of 2-
ketoarginine and L-alanine in the proposed reaction by AruH. Two transamination 
reaction mixtures were prepared, one with active AruH and another with heat-inactivated 
AruH as negative control. As shown in Fig. 2.3, the presence of 2-ketoarginine in the 
reaction was tentatively identified by HPLC: a peak with the same retention time (5.9 
min) as 2-ketoarginine standard only appeared in the reaction mixture of active AruH but 
not in the negative control. However, the presence of L-alanine was difficult to 
demonstrate by HPLC because of its relatively low molar extinction coefficient (79 
versus 1350 M-1cm-1of L-arginine) at 205 nm and its close retention time (3.36 min) to L-
arginine (3.42 min) under this elution condition. 
The same reaction mixtures were also analyzed by MS to detect the presence of L-
alanine and 2-ketoarginine. In the mass spectrum of the reaction mixture with active 
AruH (Fig. 2.4B), two molecular ion peaks were observed with m/z(-) value of 88.1 and 
172.1, which are identical to those of authentic L-alanine and 2-ketoarginine, 
respectively. As expected, no L-alanine and 2-ketoarginine were detected in the negative 
control sample which contained heat-inactivated AruH (Fig. 2.4A). Taken together, these 
results indicated that AruH is a PLP-dependent arginine:pyruvate transaminase that yields 
2-ketoarginine and L-alanine.  
We also investigated the reverse reaction catalyzed by AruH using 2-ketoarginine and 
L-alanine as substrates. No significant production of L-arginine or pyruvate, however, 
was observed from HPLC analyses as described in Materials and Methods. This could be 
due to the fact that our assay conditions were not optimal for the reverse reaction. 
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2.3.4 Optimal pH and temperature.  
As shown in Fig. 2.5, the optimal pH for AruH enzyme activity was pH 9.0. 
Borate/NaOH buffer in this case showed a strong inhibition effect on the transamination 
activity of AruH. The optimal temperature for AruH enzyme activity was 42°C; the 
enzyme was prone to a sharp thermal inactivation above this temperature (Fig. 2.6).  
 
2.3.5 Steady state kinetics with L-arginine and pyruvate as substrates.  
Taking L-arginine and pyruvate as the substrates, Lineweaver-Burk plots of the data 
revealed a series of parallel lines characteristic of ping-pong kinetics mechanism (Fig. 
2.7A and 2.7B). The calculated Vmax and kcat were 54.6 ± 2.5 µmol/min/mg and 38.6 ± 
1.8 s-1. The apparent Km and catalytic efficiency (kcat/Km) for pyruvate were 1.6 ± 0.1 
mM and 24.1 mM-1 s-1, respectively. The apparent Km and catalytic efficiency (kcat/Km) 
for L-arginine were 13.9 ± 0.8 mM and 2.8 mM-1 s-1, respectively.  
 
2.3.6 Substrate specificity.  
AruH was tested with ornithine, D-arginine and nineteen natural amino acids (except 
L-alanine) as amino donors in the presence of pyruvate as the amino acceptor. While L-
arginine was found to be the best substrate among these amino acids, AruH also exhibited 
the catalytic activity toward L-lysine, L-methionine, L-leucine, ornithine and L-glutamine 
with less efficiency (TABLE 2.1). In the mass spectrum of the reaction mixture with L-
lysine as substrate (Fig. 2.8), a molecular ion peaks was observed with m/z(-) value of 
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126.1, which suggests the production of ∆1-piperideine-2-carboxylate. As expected, no 
such signal peak was detected in the negative control sample which contained inactivated 
AruH (Fig. 2.8). These results indicated that AruH is a transaminase with broad substrate 
specificity. 
We also tested whether α-ketoglutarate could substitute pyruvate as an alternative 
amino acceptor in the AruH-catalyzed deamination of L-arginine and L-lysine. However, 
no synthesis of glutamate could be detected in a coupled reaction with NAD+-dependent 
glutamate dehydrogenase. 
 
2.4 DISCUSSION 
To our knowledge, this is the first report of an arginine transaminase being 
characterized at the molecular level. We provided solid evidences herein to support that 
AruH is a PLP-dependent arginine:pyruvate transaminase. In conjunction with genetic 
studies in Chapter One (Yang and Lu, 2007b), we established the physiological function 
of AruH as the first catalytic enzyme of the arginine transaminase pathway for L-arginine 
utilization in P. aeruginosa. The high Km value of AruH for L-arginine (13.9 ± 0.8 mM) 
might provide an explanation why the arginine transaminase pathway in P. aeruginosa is 
not the preferred pathway and only active when the major pathway, the arginine 
succinyltransferase (AST) pathway is blocked. Like many other arginine catabolic 
enzymes, AruH also displayed an optimal pH at 9.0 which might be due to intracellular 
alkaline environment through arginine utilization.  
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In pseudomonas genome annotation (www.pseudomonas.com), AruH was initially 
described as an aspartate transaminase (AspTA) because of its significant sequence 
similarities to other bacterial AspTAs, which belong to subgroup I of the transaminase 
family (Mehta et al., 1993). The AspTAs in subgroup I may be further subdivided into 
two subgroups, Ia and Ib, according to their mutual homologies (Okamoto et al., 1996). 
AruH showed significant sequence identities (27%-39%) and similarities (47-57%) with 
AspTAs of subgroup Ib but not with those of subgroup Ia. For AspTAs, an R-292 residue 
of subgroup Ia (Fotheringham et al., 1986) or a K-109 residue of subgroup Ib (Nobe et 
al., 1998) is highly conserved to interact with the distal carboxyl group of aspartate. None 
of these two residues is conserved in the corresponding sites of AruH, consistent with our 
conclusion that AruH is not an aspartate transaminase. Since L-arginine is the best 
substrate for AruH, one would expect the presence of specific interactions between the 
guanidino group of L-arginine and the side chains of amino acid residues in the catalytic 
pocket of this enzyme. Although the comparison of predicted 3D structure of AruH and 
the known structure aspartate transaminase (Thermus Thermophilus) could not offer the 
hints (Fig. 2.11), future determination of the molecular structure of AruH would expect to 
answer these questions of substrate recognition mechanism. It was noteworthy, however, 
that those amino acid invariants well conserved in AspTAs of subgroup I (Mehta et al., 
1989), including Y70, P138, N194, P195, G197, D222, Y225, K258, R266, G268, and 
A386 (the residues are numbered according to pig cytosolic AspTA), could still be found 
in the sequence of AruH (Fig. 2.10). Analogous to the roles played by these residues in 
members of the transaminase family subgroup I, we propose that K-237 of AruH is the 
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active lysyl residue that binds to the coenzyme PLP, D-204 of AruH may form a 
hydrogen bond to N(1) of the coenzyme, and R365 of AruH may function in binding the 
α-carboxyl group of substrates.  
The conversion of L-arginine into 2-ketoarginine via transamination has been 
previously reported in Arthrobacter simplex (Tachiki et al., 1980). Different from the 
arginine:2-ketoglutarate transaminase of A. simplex, AruH prefers to use pyruvate as the 
amino acceptor, but not 2-ketoglutarate. Those two enzymes are, however, both PLP-
dependent and showed an arginine-inducible expression profile. Compared to the enzyme 
of A. simplex which could utilize L-arginine (100%) but also L-citrulline (16%) and L-
alanine (10%), AruH displayed broader substrate specificity and could utilize L-lysine 
(51%), L-methionine (44%), L-leucine (24%), and L-ornithine (17%) besides L-arginine 
(100%) as the amino donor. It would be of interest to exploit whether AruH plays a role 
in utilization of these amino acids, and reciprocally whether these amino acids exert any 
effect on induction of aruH and other genes in the same locus. For instance, the 
production of ∆1-piperideine-2-carboxylate via the transamination between L-lysine and 
pyruvate as demonstrated in this report might provide an alternative pathway for lysine 
catabolism (Revelles et al., 2005). 
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TABLE 2.1. Substrate specificity of AruH. 
 
Amino donor Relative activity (%)a
L-arginine 100 
L-lysine 51 
L-methionine 44 
L-leucine 24 
L-ornithine  16.5 
L-glutamine 2.3 
Other amino acidsb NRc
 
 
 
 
a Pyruvate (20 mM) and amino donors (20 mM) as indicated were used as substrates, and 
the initial reaction rate was measured by analyzing L-alanine production in the coupled 
reaction as described in Materials and Methods. The activity of AruH with L-arginine as 
substrate was defined as 100%. All experiments were performed in duplicate. 
b Other amino acids tested as the amino donor included all other L-amino acids (except 
L-alanine) and D-arginine. 
c NR, not reactive or the activities were below the detection limit of the employed 
method. 
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FIG. 2.1. Purification of the recombinant AruH. Proteins were separated on a 10% SDS-
polyacrylamide gel. Lane M, protein markers with sizes shown on the right; lane 1, cell-
free extract before purification; lane 2, the AruH fraction from the affinity column; lane 
3, the AruH fraction from the anion exchange column.  
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FIG. 2.2. Dimeric state of recombinant AruH. Known protein standards (solid squares) 
were used to calculate a standard curve. The recombinant AruH proteins were eluted with 
an apparent molecular mass of 79.3 kDa. The r2 value for the linear regression of the 
standard curve was 0.974. 
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FIG. 2.3. HPLC analysis of the AruH reaction products. Chromatograms of components 
of the reaction mixture either with heat-inactivated AruH (dashed line) or active AruH 
(solid line) were recorded at 205 nm as described in Materials and Methods. Signal peaks 
were individually identified, according to the same retention times as of authentic 
reference compounds. In this system, the retention times for L-arginine (L-arg), pyruvate 
(Pyr), 2-ketoarginine (2-KA), L-alanine and PLP were 3.42 min, 4.2 min, 5.9 min, 3.36 
min and 10.8 min, respectively. 
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FIG. 2.4. ESIMS analysis of the AruH reaction products using L-arginine as substrate. Panels A and B represent analyses of 
the reaction mixture with the heat-inactivated and the active AruH, respectively. The signals with an m/z of 87.0, 88.1, 172.1, 
and 173.2 were in accordance with the negative ion of pyruvate (Pyr), L-alanine (L-ala), 2-ketoarginine (2-KA), and L-
arginine (L-arg).  
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FIG. 2.5. The effect of pH on AruH activity. The arginine:pyruvate transaminase 
activities of AruH at pH 6.0-10.0 and 37°C were determined as described in Materials 
and Methods. The reaction mixture contained 20 mM of L-arginine and pyruvate in 70 
mM of the following buffers: potassium phosphate pH 6.0-8.0 (filled circles); Tris-HCl 
pH 7.5-9.5 (open circles); borate/NaOH pH 9.0-10.0 (filled triangles). For comparison, 
the specific activity of AruH at pH 9.0 in Tris-HCl was defined as 100%. All experiments 
were performed in triplicate, and the averages of specific activities were used for 
comparison.  
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FIG. 2.6. The effect of temperature on AruH activity. Figure shows the arginine:pyruvate 
transaminase activity of AruH at temperature from 25-50 °C with 20 mM L-arginine and 
20mM pyruvate. For comparison, the specific activity of AruH at 42 °C was defined as 
100%. Each assay was initiated by the addition of 10 µg of recombinant AruH. All 
experiments were performed in triplicate, and the averages of specific activities were 
used for comparison.  
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FIG. 2.7. Lineweaver-Burk plot of AruH activities with L-arginine and pyruvate as 
substrates. Kinetic studies were performed as described in Materials and Methods. Panel 
A, the concentration of L-arginine (L-arg, the amino donor) was varied at the fixed 
concentrations of pyruvate (Pyr, the amino acceptor) as indicated.  Panel B, the 
concentration of pyruvate was varied at the fixed L-arg concentrations as indicated. All 
experiments were performed in triplicate, and error bar denotes the standard deviation. 
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FIG. 2.8. ESIMS analysis of the AruH reaction products using L-lysine as substrate. Panels A and B represent the ESIMS 
analysis of the reaction mixture with heat-inactivated and active AruH, respectively. The signals with an m/z of 87.0, 88.1, 
126.1 and 145.1 were in accordance with the negative ion of pyruvate (Pyr), L-alanine (L-ala), ∆1-piperideine-2-carboxylate, 
and L-lysine (L-lys).  
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FIG. 2.9. UV/VIS spectroscopic analysis of AruH and authentic PLP. Absorption spectra 
of the purified protein (8 mg/ml) and authentic PLP (1 mM) dissolved in 20 mM 
Tris/HCl (pH7.4) were recorded at 25°C. 
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FIG. 2.10. Comparison of the sequences of aminotransferase from different species. The residues are numbered according to 
the sequence of pig cytosolic AspAT (cPig). AruH, arginine:pyruvate transaminase from P. aeruginosa; PFL2715, AruH 
homolog from P. fluorescence; PP3721, AruH homolog from P. putida; B. SP. YM-2, thermostable AspAT from Bacillus sp. 
strain YM-2; ThermusHB8, AspAT from Thermus thermophilus strain HB8; Sulfolobus, AspAT from Sulfolobus solfataricus; 
PA3139, AspAT from P. aeruginosa. Residues that are invariant in all the compared sequences are highlighted. 
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FIG. 2.11. Structure of comparison of Thermus Thermophilus aspartate transaminase (left) and Pseudomonas aeruginosa AruH 
(right) with front view. The predicted structure of Pseudomonas aeruginosa AruH was proposed using Adanced Molecular 
Modeling Program (AMMP) and the structure of Thermus Thermophilus aspartate transaminase as the template. 
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Chapter Three  
Identification of Candidate Genes for D-arginine Catabolism in P. aeruginosa PAO1 
Using DNA Microarray. 
 
3.1. INTRODUCTION 
We provided the solid evidences (Yang and Lu, 2007a; Yang and Lu, 2007b) to 
support that in P. aeruginosa PAO1 L-arginine is converted into 2-ketoarginine via 
transamination instead of oxidative deamination by D-arginine dehydrogenase coupled 
with arginine racemase as originally proposed when the major pathway for arginine 
utilization, the arginine succinyltransferase (AST) pathway, is blocked. Our results also 
showed that the block of the AST and ATA pathways abolished the capacity of P. 
aeruginosa to utilize L-arginine as the sole source of carbon and nitrogen (Yang and Lu, 
2007b), thus indicating that no other alternative routes for L-arginine utilization exist in 
this microorganism. Although, our studies have ruled out the significance of D-arginine-
inducible D-arginine dehydrogenase in L-arginine utilization; this yet-to-be-identified 
enzyme could still provide routes for D-arginine utilization. Since P. aeruginosa could 
grow on D-arginine as the only carbon and nitrogen source (Itoh, 2004; Jann et al., 1988), 
the physiological functions of D-arginine dehydrogenase in arginine metabolism warrant 
further investigation.  
Traditional methods to identify genes of metabolic pathway usually are time 
consuming. With the completion of the P. aeruginosa Genome Project (Stover et al., 
2000) and the development of innovative DNA microarray technology, it becomes 
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feasible to identify the unknown genes of metabolic pathway in an efficient and 
systematic way. As demonstrated by our previous work (Lu et al., 2004; Yang and Lu, 
2007b), this technology is especially useful for the study of cell metabolism. Thus, to 
identify the candidates for D-arginine dehydrogenase in P. aeruginosa, we still decided to 
employ DNA microarray technology to analyze the transcriptional profiles of this 
organism in response to D-arginine.  
 
3.2. MATERIALS AND METHODS  
3.2.1 D-arginine dehydrogenase assay. 
For the measurements of enzyme activities, cell cultures in the logarithmic phase were 
collected by centrifugation, and the cell pellets were washed twice using 50 mM 
potassium phosphate buffer, pH 7.0, and resuspended in the same buffer. Cells were 
broken with a French pressure cell at 8,000 lb/in2, and soluble cell extracts were prepared 
after centrifugation at 25,000 x g for 20 min. Protein concentration was determined by the 
method of Bradford with bovine serum albumin as the standard. 
D-arginine dehydrogenase was assayed with the addition of artificial electron 
acceptors, phenazine methosulphate (PMS) and iodonitrotetrazolium chloride (INT), as 
described by Jann and Haas (Jann et al., 1988). Briefly, the assay mixture (1.0 ml; final 
volume) contained 0.1 M Tris/HCl (pH 8.7), 20 mM D-arginine, 10mM potassium 
cyanide, 0.8 mM INT, 0.8 mM PMS, and crude extract (0.1-1.0 mg protein). The assay 
mixture was pre-incubated for 10 min at 37 °C prior to the addition of INT, PMS and 
crude extract. The reaction was stopped by the addition of 0.1 ml 4 M HCl, and the 
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increase of the absorbance at 500 nm was measured. Blanks did not contain D-arginine or 
crude extract. The molar extinction coefficient (11500 M-1 cm-1) of reduced INT was 
used for calculation. One unit of D-arginine dehydrogenase activity is defined as the 
amount of the enzyme that led to the reduction of 1 nmol of INT per minute under the 
standard assay conditions. 
 
3.2.2 DNA microarray. 
Our GeneChip®
 
(Affymetrix) experiments were done as described in Materials and 
Methods of Chapter One (Yang and Lu, 2007b). Total RNA samples were prepared from 
wild-type strain PAO1 grown in glutamate minimal medium in the presence or absence 
of D-arginine under aerobic conditions using Qiagen RNeasy Kit. cDNA synthesis, 
fragmentation, labeling, and GeneChip hybridization were performed according to the 
protocol provided by the manufacturer (Affymetrix) as described in Chapter One (Yang 
and Lu, 2007b). The results of two independent experiments for D-arginine conditions 
were merged, and the merged data were used for subsequent comparisons and assessed 
with Microarray Suite 5.0 software (Affymetrix). Absolute expression signal values were 
normalized for each chip by globally scaling to a target intensity of 500. These data were 
imported into the GeneSpring 6.1 software (Silicon Genetics) for further analysis based 
on distinct expression patterns under these three conditions. Transcripts with the absence 
call (P > 0.04) or with a signal level below 400 were eliminated. 
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3.2.3 Construction of lacZ fusions.  
Plasmid pQF52 (Park et al., 1997a), a broad-host-range lacZ translational fusion 
vector, was used in the construction of promoter fusions of PA3862 and PA3865. DNA 
fragments containing the regulatory regions of interest were amplified by PCR from the 
genomic DNA of PAO1 with the following synthetic oligonucleotides designed to 
generate HindIII restriction sites on the forward primers: for PA3862, 5’-
TACAAGCTTCTGTACAACCTGGTGGCGCAG-3’ and 5’-GGCGCTCATGCGATCT 
CCGGAATGGATGTA-3’; and for PA3865, 5’-AGCAAGCTTCCCCCATTACAGACG 
CGCCTC-3’ and 5’-GGTGTTCAGCGACTTGATCATGGACGACTC-3’. The PCR 
products were purified from a 1% (wt/vol) agarose gel, digested by restriction 
endonuclease HindIII, and ligated to the HindIII and SmaI sites of the translational fusion 
vector pQF52. The resulting plasmids contain the entire upstream intergenic sequences of 
the corresponding genes and the 5' ends of their coding sequences fused in-frame to the 
eighth codon of the lacZ gene in the vector.  
 
3.2.4 Construction of mutant strain.  
Deletion mutant of PA3862-to-PA3862 was constructed as described below. DNA 
fragments covering two flank regions of those genes were generated by PCR from the 
genomic DNA of PAO1 with the following synthetic oligonucleotides designed to 
generate restriction sites at the 5’ or 3’ ends of the PCR products: for PA3862 side flank 
region, 5’-TTTGGATCCGGCGATCGTCGAGATCGAGCC-3’ (BamHI) and 5’-GTTG 
AATTCTGGACTTTAAGGTATTGCCGG-3’ (EcoRI); for PA3865 side flank region,  
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5’-GAGGAATTCGGGTCCTTGAACTCCGGCCCG-3’ (EcoRI) and 5’-GGGAAGCTT 
CGACTACGACATCGGCAACGC-3’ (HindIII). The PCR products were purified and 
subcloned into the corresponding site of the conjugation vector pRTP1 (Stibitz et al., 
1986), followed by insertion of a gentamicin resistance cassette (Gm) into the EcoRI site. 
For gene replacement, the resulting transposon insertion plasmids were first introduced 
into E. coli SM10 and then mobilized into the spontaneous streptomycin-resistant P. 
aeruginosa strain PAO1-Sm by biparental plate mating (Gamper et al., 1991). After 
incubation at 37°C overnight, transconjugants were selected on LB plates supplemented 
with gentamicin and streptomycin. Genotypes of all these constructed mutants were 
verified by PCR.
 
3.3 RESULTS AND DISCUSSION 
3.3.1 Assay of D-arginine dehydrogenase.  
As shown in Table 3.2, D-arginine dehydrogenase activity was induced specifically 
by D-arginine, but not by L-arginine. However, L-arginine did exert a significant 
induction effect on D-arginine dehydrogenase activity in the aruF mutant in which the 
major route of arginine utilization, the AST pathway, was blocked. Since aruF encodes 
an arginine succinyltransferase catalyzing the first step of the AST pathway, it is possible 
that the intracellular concentration of L-arginine in the aruF mutant was higher than that 
in the wild type strain, and this may induce the arginine racemase activity and 
subsequently the D-arginine dehydrogenase activity. 
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P. aeruginosa could grow on D-arginine as the only carbon and nitrogen source (Itoh, 
2004; Jann et al., 1988), although more slowly (doubling time 2 h) than on L-arginine 
(doubling time 1.3 h, Table 1.5). We also have observed that D-arginine utilization was 
partially retarded in the aruF mutant devoid of the AST pathway (doubling time 4 h), 
suggesting the AST pathway is also the major route for D-arginine utilization. Because 
D-arginine is a competitive inhibitor of the arginine succinyltransferase catalyzing the 
first reaction of the AST pathway, D-arginine may have to be converted by a racemase 
into L-arginine before it can be channeled into the AST pathway (Jann et al., 1988). 
However, we could not exclude the possibility that D-arginine may serve as a substrate of 
this enzyme. When the AST pathway was blocked, disruption of the ATA pathway in the 
aruF mutant by either aruH or aruI did not result in further inhibition of growth on D-
arginine, thus indicating the presence of other alternative D-arginine catabolic pathways 
in which D-arginine dehydrogenase may be involved.  
 
3.3.2 Identification of genes induced by D-arginine in P. aeruginosa PAO1. 
To identify and characterize the genes of D-arginine utilization in P. aeruginosa, we 
employed DNA microarray to analyze the transcriptional profile of this organism in 
response to D-arginine. We hypothesized that D-arginine catabolic genes should be 
induced by D-arginine. Our transcriptome analyses identified 39 genes in 19 putative 
transcriptional units (Table 3.1) falling into this group.  
While many of these genes have not been characterized, the following observations 
are interesting. First, the genes of the AST pathway, aruCFGDBE, were found to be also 
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induced by D-arginine. This fits well to the hypothesis that D-arginine may be converted 
by a racemase to L-arginine, which will be subsequently channeled into the AST 
pathway. Second, PA3862-to-PA3864 and PA3865 genes were found to be highly 
induced by D-arginine. Among these genes, PA3863 encode a putative oxidoreductase, 
which could serve to catalyze the conversion of D-arginine into 2-ketoarginine as a D-
arginine dehydrogenase. These genes were also revealed in our previous transcriptome 
analyses, but the expression of those genes were induced by L-arginine to much lesser 
extent when compared to D-arginine. This might be explained by the distinct property of 
D-arginine dehydrogenase, which is a specific D-arginine inducible enzyme. Third, the 
gene cluster (PA1974-to-PA1990) was related to the biosynthesis of pyrroloquinoline 
quinone (PQQ) (Goosen et al., 1992; Schnider et al., 1995; Velterop et al., 1995). This 
molecule has similarity to vitamin B2 and vitamin B3, and is proven to be an important 
cofactor in enzyme-catalyzed reduction–oxidation (redox) reactions. The co-induction of 
this gene cluster with D-arginine dehydrogenase by D-arginine in P. aeruginosa PAO1 
may suggest that PQQ functions as a cofactor for D-arginine dehydrogenase. Last, the 
gbuA gene, which encodes 4-guanidinobutyrase of the ATA pathway, was also identified 
in this list. The kauB gene encoding a bifunctional dehydrogenase for 4-
aminobutyraldehyde of the ADC pathway and a 4-guanidinobutyraldehyde (GUBAL) of 
the ATA pathway, and the gabDT genes encoding parts of the ADC and ATA pathways, 
however, were not identified as a D-arginine inducible gene. These unexpected results 
strongly suggested that D-arginine might be utilized via a yet-to-be-identified pathway, 
instead of via the ATA pathways as previous proposed.  
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3.3.3 Validation of microarray data by promoter::lacZ fusions.  
To validate microarray data, putative promoters for PA3862-to-PA3864 and PA3865 
were selected for further analysis by lacZ fusions. These promoter::lacZ fusions were 
constructed as described in Materials and Methods, and the effect of exogenous D-
arginine on expression of these promoters was analyzed by measurements of β-
galactosidase activities in wild type strain PAO1 harboring the recombinant plasmids.  
As shown in Table 3.3, while exogenous D-arginine exerted 14.2-fold and 7.1-fold of 
induction on the PA3862 and PA3865 promoters respectively in wild type strain PAO1, 
we did not observe the similar induction effect by exogenous L-arginine. Overall, these 
results correlated well with microarray data in the induction pattern, and supported our 
hypothesis that PA3863 may encode a D-arginine dehydrogenase for D-arginine 
utilization by P. aeruginosa. 
On the other hand, the results of transcriptome analysis did not support the proposed 
pathway of D-arginine utilization as shown in Fig.3.1 (Jann et al., 1988). Specifically, the 
kauB gene encoding GUBAL dehydrogenase and gabDT for the conversion of GABA 
into succinate were not found in the list. These results depicted a wider network of 
arginine metabolism than we previously recognized. 
 
3.3.4 PA3862-to-PA3865 mutant. 
To test our hypothesis that PA3863 may encode a D-arginine dehydrogenase, the 
deletion mutant of PA3862-to-PA3865 was constructed as described in Materials and 
Methods. As shown in Table 3.2, while a D-arginine inducible D-arginine dehydrogenase 
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activity was detected in P. aeruginosa wild type strain PAO1 and its aruF mutant 
PAO4558, this activity was abolished when a PA3862-to-PA3865 deletion was 
introduced to the strain. This result supported the proposed biochemical function of 
PA3863 and its potential role in D-arginine utilization. 
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TABLE 3.1. Microarray analysis of genes induced by D-arginine P. Aeruginosa PAO1 
 
Absolute signal valuebGene no.a Gene name Protein description PAO 1 (E)     PAO1 (ER1)    PAO1 (ER2) 
PA0565  Unknown 245 6,686 3,127 
PA0567  Unknown 53 619 628 
PA0895 aruC N-Succinylglutamate 5-semialdehyde dehydrogenase 849 5,749 5,134 
PA0896 aruF Arginine/Ornithine succinyltransferase AI subunit  529 3,409 4,733 
PA0897 aruG Arginine/Ornithine succinyltransferase AII subunit  377 3,900 3,459 
PA0898 aruD Succinylglutamate 5-semialdehyde dehydrogenase  284 3,086 2,524 
PA0899 aruB Succinylarginine dihydrolase  466 4,299 3,631 
PA0900  Unknown 2,880 8,775 7,109 
PA0901 aruE Succinylglutamate desuccinylase  691 2,683 2,986 
PA1323  Unknown 140 1,021 1,398 
PA1421 gbuA Guanidinobutyrase 67 397 1,488 
PA1471  Unknown 338 3,341 2,770 
PA1818  Ornithine/Arginine/Lysine decarboxylase 739 3,797 2,469 
PA1974  Unknown 28 2,448 375 
PA1975  Unknown 47 3,262 1,279 
PA1976  Two-component sensor 39 1,406 1,278 
PA1977  Unknown 97 768 243 
PA1978  Transcriptional regulator 198 5,690 1,244 
PA1979  Two-component sensor 3 415 247 
PA1980  Two-component regulator 11 354 270 
PA1981  Unknown 41 9,246 7,629 
PA1982 exaA Quinoprotein alcohol dehydrogenase 54 13,309 6,795 
PA1983 exaB Cytochrome c550 14 14,476 6,799 
PA1984  Unknown 1,911 13,810 7,646 
PA1985 pqqA Pyrroloquinoline quinone biosynthesis protein A 116 3,997 2,122 
PA1986 pqqB Pyrroloquinoline quinone biosynthesis protein B 188 6,113 3,806 
PA1987 pqqC Pyrroloquinoline quinone biosynthesis protein C 174 5,229 3,079 
PA1988 pqqD Pyrroloquinoline quinone biosynthesis protein D 240 6,313 3,680 
PA1989 pqqE Pyrroloquinoline quinone biosynthesis protein E 159 2,543 1,697 
PA1990  Unknown  64 1,308 1,164 
PA3441  Molybdopterin-binding protein 149 747 821 
PA3819  Unknown 599 4,819 4,308 
PA3862  Unknown 215 10,699 7,718 
PA3863  FAD dependent oxidoreductase 81 3,933 2,561 
PA3864  Unknown 158 2,495 1,893 
PA3865  Amino acid binding protein 205 4,229 5,451 
PA5182  Unknown 933 5,043 5,788 
PA5212  Unknown 544 4,674 4,801 
PA5526  Unknown 135 898 1,385 
 
a Gene numbers are from the Pseudomonas Genome Project (www.pseudomonas.com). 
Genes that were also induced by agmatine, putrescine and spermidine were marked with 
asterisks. The expression profiles of argF and aruF at the end of this list represented 
ArgR-dependent repression and activation, respectively. 
b Abbreviations: E, cells were grown in glutamate minimal medium P (MMP); ER, cells 
were grown in glutamate MMP supplied with 20 mM L-arginine. 
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TABLE 3.2. Measurements of D-arginine dehydrogenase activities in P. aeruginosa 
PAO1 and its mutant strains. 
 
Sp acta (u / mg proteins) Strains (Genotype) Glu Glu + L-arg Glu + D-arg 
PAO1 (wild type) <0.1 2 836 
PAO4558 (aruF) <0.1 215 826 
∆PA3862-to-PA3865 <0.1 <0.1 59 
 
a Cells were cultured to mid-log phase (OD600 = 0.5) in MMP-glutamate medium with or 
without D-arginine and L-arginine. Cell extracts preparation and the enzyme assays were 
described in Materials and Methods. 
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TABLE 3.3. Verification of microarray data by promoter-lacZ fusions. 
 
Sp actb (µmol/min/mg) Gene no. 
(name)a 
Host strain 
(genotype) Glu Glu + L-arg Glu + D-arg 
PA3862 PAO1 (wild type) 26 34 372 
PA3865 PAO1 (wild type) 350 91 2,467 
 
a Gene numbers and names are from the Pseudomonas Genome Project 
(www.pseudomonas.com). 
b Specific activities are average of three measurements for each growth condition, with 
standard errors of less than 5%. Glu, cells were grown in glutamate minimal medium P 
(MMP); Glu+L-Arg, cells were grown in glutamate MMP supplied with 20 mM L-
arginine; Glu+D-Arg, cells were grown in glutamate MMP supplied with 20 mM D-
arginine. 
c Fold changes of gene expression are indicated by the ratio of cells grown in glutamate 
MMP in the presence of arginine to cells grown in glutamate MMP in the absence of 
arginine. 
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FIG. 3.1. D-arginine catabolic pathways in P. aeruginosa PAO1. Only relevant 
intermediates and genes are indicated. AST, arginine succinyltransferase pathway; ATA, 
arginine transaminase pathway; TCA, tricarboxylic acid. Illustrated were four possible 
routes for D-arginine utilization: 1) direct route through the AST pathway; 2) D-arginine 
to L-arginine via arginine racemase, followed by the AST pathway; 3) the D-arginine 
dehydrogenase pathway as originally proposed; and 4) D-arginine to 2-ketoarginine via 
D-arginine dehydrogenase, followed by unknown steps. Other abbreviations are shown as 
in Figure 1.1. 
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Overall Summary 
Pseudomonas aeruginosa is a Gram-negative bacterium that causes life-threatening 
infections in immunocompromised persons and chronic infections in cystic fibrosis 
patients. The potential pathogenicity of this opportunistic human pathogen is greatly 
enhanced by its extraordinary nutritional versatility, which gives it an exceptional ability 
to colonize ecological niches where nutrients are limited. Arginine catabolism is of 
particular significance in this regard because P. aeruginosa can utilize L-arginine 
efficiently as the sole source of carbon, nitrogen and energy through different pathways, 
including the arginine deiminase (ADI) pathway, the arginine succinyltransferase (AST) 
pathway, and the arginine transaminase (ATA) pathway recently reported by our research 
group. Our results indicate that the AST and ATA pathways are the only two functional 
routes for L-arginine utilization under aerobic conditions. The arginine decarboxylase 
(ADC) pathway may not contribute to arginine utilization due to the lack of an arginine-
inducible ADC activity, but rather serve to supply putrescine when arginine is abundant. 
Nevertheless, exogenous agmatine or putrescine indeed can induce all the enzymes 
following its entry point of the ADC pathway, and thus be utilized as the sole source of 
carbon and nitrogen through this pathway.  
Functional genomics approach using DNA microarray is an appropriate and efficient 
way to identify genes of metabolic pathways in organisms with completed genome 
projects. In this case, P. aeruginosa genome contains 5,570 open reading frames, and 
traditional genetic approach of random mutagenesis was proven to be difficult for the 
identification of the remaining unknown genes for arginine catabolism. We chose DNA 
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microarray to analyze the transcriptional profiles of this organism in response to L-
arginine. We used data mining method to identify the ArgR-independent arginine-
inducible genes, thus successfully dramatically decreasing the number of candidate genes 
in the first shot. With the help of bioinformatics tools including but not limited to 
sequence homology analysis and conserved motif search, we chose only seven genes 
encoding putative enzymes for the proposed pathway for the further investigation. Our 
study finally led to the revision of the arginine transaminase (ATA) pathway, the first 
report of an arginine:pyruvate transaminase, and the identification of genes which encode 
2-ketoarginine decarboxylase and arginine responsive two-component regulator proteins.  
Based on our experimental results, we also proposed a model (Fig. 4.1) to explain 
why the genes of the ATA pathway showed the expression pattern as argR independent 
and arginine inducible genes. In the presence of a functional ArgR protein, P. aeruginosa 
chooses the AST pathway as a preferred a route to utilize L-arginine, and therefore the 
genes of this pathway is induced. Since the ATA pathway is not active at this time, the 
genes of the ATA pathway show basal level of expression. When the activator 
responsible for the arginine induction effect of the AST pathway, the ArgR protein is 
inactivated, the genes of the AST pathway will not be induced by L-arginine any more, 
thus leading to the block of this major arginine catabolic pathway. Under this 
circumstance, P. aeruginosa will be forced to choose an auxiliary route, the ATA 
pathway, to utilize L-arginine. While all the genes of the AST pathway belong to a single 
operon, the aru operon, and co-regulated by the ArgR protein, the genes of the ATA 
pathway is not clustered together and may be divided into different regulatory units 
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independent of the ArgR protein. Since those genes are still the arginine catabolic genes, 
they displayed a gene expression pattern as argR independent and arginine inducible 
genes. 
Moreover, although we haven’t completed that project yet, DNA microarray also 
gave us a very promising data which may help to illustrate the unknown catabolic 
network for D-arginine utilization in P. aeruginosa PAO1. PA3863 encoding a D-
arginine dehydrogenase and the remaining steps after 2-ketoarginine yet to be identified 
warrant future investigations. 
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FIG. 4.1. Proposed model for L-arginine utilization in P. aeruginosa PAO1. 
Abbreviations are shown as in Figure 1.1. 
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